DECOR Information for Project: CDA-CH-EMED eMedication (cdachemed-) |
HTML | Name | Effective Date | Version Label | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Templates with direct association to a transaction | ||||||||||||
html | ![]() |
2016‑05‑13 | 2017 | |||||||||
The Medication Card document (IPAG:eCurrentMedication, different view) describes the current medication of a patient, medications (*) that have been or will be taken by the patient. ... | ||||||||||||
|
||||||||||||
html | ![]() |
2016‑05‑21 | 2017 | |||||||||
The Medication Dispense document (IPAG report: eDispense) describes the direct dispensation of a (1) drug to a patient or legitimized third party with regard to a later application of the product b... | ||||||||||||
|
||||||||||||
html | ![]() |
2018‑01‑22 15:17:26 | 2017 | |||||||||
The Medication List document (IPAG:eCurrentMedication) aims to fully comprise the current medication of a patient. It consists of Medication Treatment Plan, Medication Prescription, Medication Dispe... | ||||||||||||
|
||||||||||||
html | ![]() |
2016‑05‑21 | 2017 | |||||||||
The Medication Prescription document (IPAG report: eRezept) describes the content and format of a Prescription document generated during the process in which a health care professional decides that ... | ||||||||||||
|
||||||||||||
html | ![]() |
2017‑04‑12 13:57:31 | 2017 | |||||||||
The Medication Treatment Plan document (IPAG report: eMedicationTreatmentPlan) describes one medication of a patient, a (1) medication that has been, is or will be taken by the pat... | ||||||||||||
|
||||||||||||
html | ![]() |
2016‑05‑21 | 2017 | |||||||||
The Pharmaceutical Advice document (IPAG:eMedicationComment) is a document in which health professionals track important observations (with the explicit consent of the patient), in regards to medic... | ||||||||||||
|
||||||||||||
CDA Document Level Template | ||||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||
This document template is used as the primary base for CDA-CH exchange formats. All CDA-CH V2 derivatives, i.e. Swiss exchange formats SHALL use this template by specialisation. It only specifies th... | ||||||||||||
html | ![]() ref
ch-pharm-
|
2018‑01‑17 16:46:48 | PRE 2017 | |||||||||
The Community Prescription specification includes a Prescription section to capture Prescription Items prescribed to a patient as well as supporting sections containing information related to this pre... | ||||||||||||
html | ![]() ref
ch-pharm-
|
2018‑01‑17 17:33:23 | MTP 2017 | |||||||||
A document containing one Medication Treatment Plan Item representing one medication included in the global treatment plan of the patient. | ||||||||||||
html | ![]() ref
ch-pharm-
|
2018‑01‑17 17:47:52 | DIS 2017 | |||||||||
html | ![]() ref
ch-pharm-
|
2018‑01‑17 18:06:02 | PML 2017 | |||||||||
A document containing a set of Medication Treatment Plan-, Prescription-, Dispense- and Pharmaceutical Advice Items altogether forming a medication list of a patient. | ||||||||||||
html | ![]() ref
ch-pharm-
|
2018‑01‑17 17:57:48 | PADV 2017 | |||||||||
CDA Header Level Template | ||||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||
Information about an authenticator of a CDA document. An authenticator MUST be a person. All CDA-CH V2 derivatives, i.e. Swiss exchange formats MUST use this template by either reference or specialisa... | ||||||||||||
html | ![]() ref
ccd1-
|
2007‑04‑01 | ||||||||||
Template CDA AssignedEntity (prototype, directly derived from POCD_RM000040 MIF) | ||||||||||||
html | ![]() ref
ccd1-
|
2007‑04‑01 | ||||||||||
Deactivated hl7:asOrganizationPartOf association to break recursion | ||||||||||||
html | ![]() ref
ccd1-
|
2007‑04‑01 | ||||||||||
7.4.1 Entity Identifiers CDA Release 2.0 does not provide a mechanism to determine when two participants in different roles are in fact the same entity (i.e., an en... | ||||||||||||
html | ![]() ref
ad1bbr-
|
2005‑09‑07 | ||||||||||
Template CDA AssignedEntity (prototype, directly derived from POCD_RM000040 MIF) | ||||||||||||
html | ![]() ref
ad1bbr-
|
2005‑09‑07 | ||||||||||
Template CDA author (prototype, directly derived from POCD_RM000040 MIF) | ||||||||||||
html | ![]() ref
ad1bbr-
|
2005‑09‑07 | ||||||||||
Template CDA Authorization (prototype, directly derived from POCD_RM000040 MIF) | ||||||||||||
html | ![]() ref
ad1bbr-
|
2005‑09‑07 | ||||||||||
Template CDA componentOf (prototype, directly derived from POCD_RM000040 MIF) | ||||||||||||
html | ![]() ref
ad1bbr-
|
2005‑09‑07 | ||||||||||
Template CDA Organization (prototype, directly derived from POCD_RM000040 MIF) | ||||||||||||
html | ![]() ref
ad1bbr-
|
2005‑09‑07 | ||||||||||
Template CDA Person (prototype, directly derived from POCD_RM000040 MIF) | ||||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||
The organization in whose name this CDA document has been created (corresponds to the sender of a letter). All CDA-CH V2 derivatives, i.e. Swiss exchange formats MUST use this template by either refer... | ||||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||
Information about the person that entered information in this CDA document. It SHALL be declared, when data recorded in this document has been entered by a person other than the author but only when t... | ||||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||
A LOINC based document type of a CDA document instance including a translation to the Swiss EPR XDS.b metadata. All CDA-CH V2 derivatives, i.e. Swiss exchange formats MUST specialise this template by ... | ||||||||||||
html | ![]() |
2018‑01‑08 15:01:14 | 2017 | |||||||||
A LOINC based document type of a CDA document instance including a translation to the Swiss EPR XDS.b metadata (has to registered). | ||||||||||||
html | ![]() |
2018‑01‑08 15:01:14 | 2017 | |||||||||
A LOINC based document type of a CDA document instance including a translation to the Swiss EPR XDS.b metadata. | ||||||||||||
html | ![]() |
2018‑01‑08 15:01:14 | 2017 | |||||||||
A LOINC based document type of a CDA document instance including a translation to the Swiss EPR XDS.b metadata. | ||||||||||||
html | ![]() |
2018‑01‑08 15:34:02 | 2017 | |||||||||
A LOINC based document type of a CDA document instance including a translation to the Swiss EPR XDS.b metadata. | ||||||||||||
html | ![]() |
2018‑01‑08 15:45:25 | 2017 | |||||||||
A LOINC based document type of a CDA document instance including a translation to the Swiss EPR XDS.b metadata. | ||||||||||||
html | ![]() |
2018‑01‑08 15:40:41 | 2017 | |||||||||
A LOINC based document type of a CDA document instance including a translation to the Swiss EPR XDS.b metadata. | ||||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||
A confidentiality level of a CDA document instance according to the Swiss EPR regulation. All CDA-CH V2 derivatives, i.e. Swiss exchange formats MUST reference this template. Langu... | ||||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||
A unique identifier for each CDA document instance. All CDA-CH V2 derivatives, i.e. Swiss exchange formats MUST reference this template. | ||||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||
The RFC 1766 (ISO-639-1 and ISO 3166) based language in which the narrative texts in this CDA document instance are written. All CDA-CH V2 derivatives, i.e. Swiss exchange formats MUST reference this ... | ||||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||
Swiss Realm (CHE) of HL7 CDA. All CDA-CH V2 derivatives, i.e. Swiss exchange formats MUST reference this template. | ||||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||
Relationship to another CDA-CH V2 based document that is replaced by the current one. All CDA-CH V2 derivatives, i.e. Swiss exchange formats MUST reference this template. | ||||||||||||
html | ![]() ref
hl7chcda-
|
2016‑05‑18 | 2016 | |||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||
Unity of document versions. All CDA-CH V2 derivatives, i.e. Swiss exchange formats MUST reference this template. | ||||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||
CDA-CH V2 bases on HL7 CDA R2 (2005) and - by using this template - require a structured body. All CDA-CH V2 derivatives, i.e. Swiss exchange formats SHALL reference this template. These SHALL define... | ||||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||
Information on the patient's employer, school or other affiliated (e.g., volunteer) organization. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template by either reference or specia... | ||||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||
Information about a health service describing the context of this CDA document. All CDA-CH V2 derivatives, i.e. Swiss exchange formats MUST use this template by either reference or specialisation. | ||||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||
Information on a patient's insurance. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template by either reference or specialisation. | ||||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||
Information on a patient's insurance card. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template by either reference or specialisation. | ||||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||
Information about the legal authenticator of a CDA document. A legal authenticator MUST be a person. All CDA-CH V2 derivatives, i.e. Swiss exchange formats MUST use this template by either reference o... | ||||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||
Reference to one or more orders which led to the creation of this CDA document. It SHALL be declared, when the order reference is relevant for some reason. All CDA-CH V2 derivatives, i.e. Swiss exchan... | ||||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||
A human patient for whom this CDA document instance was created. All CDA-CH V2 derivatives, i.e. Swiss exchange formats MUST use this template by either reference or specialisation. | ||||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||
Information on a patient contact. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template by either reference or specialisation. | ||||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||
A recipient of this CDA document (corresponds to the addressee of a letter - person or organization). All CDA-CH V2 derivatives, i.e. Swiss exchange formats MUST use this template by either reference ... | ||||||||||||
CDA Section Level Template | ||||||||||||
html | ![]() ref
ad1bbr-
|
2005‑09‑07 | ||||||||||
Template CDA Informant (prototype, directly derived from POCD_RM000040 MIF) | ||||||||||||
html | ![]() ref
ch-pharm-
|
2016‑06‑06 | 2017 | |||||||||
The Dispense Section contains a description of a medication dispensed for the patient. It includes exactly one Dispense Item entry as described in the Dispense Item Entry Content Module. See also IHE... | ||||||||||||
html | ![]() ref
IHE-PCC-
|
2015‑10‑05 16:02:07 | 2014 | |||||||||
The active problem section shall contain a narrative description of the conditions currently being monitored for the patient. It shall include entries for patient conditions as ... | ||||||||||||
html | ![]() ref
IHE-PCC-
|
2013‑12‑20 | 2014 | |||||||||
html | ![]() ref
IHE-PCC-
|
2015‑10‑05 15:57:07 | 2014 | |||||||||
The vital signs section contains coded measurement results of a patient’s vital signs. | ||||||||||||
html | ![]() ref
ch-pharm-
|
2018‑01‑10 11:13:04 | 2017 | |||||||||
html | ![]() ref
IHE-PCC-
|
2013‑12‑20 | 2014 | |||||||||
The History of Past Illness section shall contain a narrative description of the conditions the patient suffered in the past. It shall include entries for problems as described in the Entry Content Mo... | ||||||||||||
html | ![]() ref
IHE-PCC-
|
2013‑12‑20 | 2014 | |||||||||
The immunizations section shall contain a narrative description of the immunizations administered to the patient in the past. It shall include entries for medication administration as described in the... | ||||||||||||
html | ![]() ref
ch-pharm-
|
2018‑01‑10 08:39:19 | 2017 | |||||||||
The Medication List section shall contain a description of the Medication Treatment Plan-, Prescription- and Dispense Items assembled to a medication list. It shall include zero to many Medication Tre... | ||||||||||||
html | ![]() ref
ch-pharm-
|
2017‑04‑03 07:47:01 | 2017 | |||||||||
The Medication Treatment Plan Section contains a description of the patient. It includes entries for Medication Treatment Plan Items as described in the Medication Treatment Plan Ite... | ||||||||||||
html | ![]() ref
ch-pharm-
|
2018‑01‑10 11:13:04 | 2017 | |||||||||
html | ![]() ref
IHE-PCC-
|
2017‑03‑20 13:38:42 | 2016 | |||||||||
The pregnancy history section contains coded entries describing the patient history of pregnancies. | ||||||||||||
html | ![]() ref
ch-pharm-
|
2018‑01‑10 11:13:04 | 2017 | |||||||||
html | ![]() ref
ch-pharm-
|
2016‑05‑21 | 2017 | |||||||||
The Meciation Card Section includes the current and planned medication of a patient. See IHE Pharmacy PML Suppl . It includes entries for Medication Treatment Plan Items as described in the Medicatio... | ||||||||||||
html | ![]() ref
ch-pharm-
|
2018‑01‑22 15:40:38 | 2017 | |||||||||
The Medication List section shall contain a description of the Medication Treatment Plan-, Prescription-, Dispense- and Medication Administration Items assembled to a medication list. It shall include... | ||||||||||||
html | ![]() ref
ch-pharm-
|
2017‑05‑01 12:51:36 | 2017 | |||||||||
The Medication Treatment Plan Section contains a description of the patient. It includes entries for Medication Treatment Plan Items as described in the Medication Treatment Plan Item Entry Content M... | ||||||||||||
html | ![]() ref
ch-pharm-
|
2016‑06‑06 | 2017 | |||||||||
The Pharmaceutical Advice section contains a pharmaceutical advice to a medication prescribed or dispensed for the patient. It shall include exactly one Pharmaceutical Advice entry as described in the... | ||||||||||||
html | ![]() ref
ch-pharm-
|
2016‑06‑06 | 2017 | |||||||||
The Prescription Section contains a description of the medications in a given prescription for the patient. It includes entries for Prescription Items as described in the Prescription Item Entry Conte... | ||||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||
This section MAY be used to provide comments, remarks or other information that cannot be declared in any of the other existing sections in the document. | ||||||||||||
CDA Entry Level Template | ||||||||||||
html | ![]() ref
ch-pcc-
|
2016‑11‑11 | 2017 | |||||||||
This entry allows for a comment to be supplied with each entry. | ||||||||||||
html | ![]() ref
ccd1-
|
2007‑04‑01 | ||||||||||
Template CDA Performer (Body) (prototype, directly derived from POCD_RM000040 MIF) | ||||||||||||
html | ![]() ref
ccd1-
|
2007‑04‑01 | ||||||||||
html | ![]() ref
ad1bbr-
|
2005‑09‑07 | ||||||||||
Template CDA Device (prototype, directly derived from POCD_RM000040 MIF) | ||||||||||||
html | ![]() ref
ad1bbr-
|
2005‑09‑07 | ||||||||||
Template CDA Place (prototype, directly derived from POCD_RM000040 MIF) | ||||||||||||
html | ![]() ref
ad1bbr-
|
2005‑09‑07 | ||||||||||
Template CDA RelatedEntity (prototype, directly derived from POCD_RM000040 MIF) | ||||||||||||
html | ![]() ref
ccd1-
|
2007‑04‑01 | ||||||||||
4.3 Comments The template identifier for a comment is 2.16.840.1.113883.10.20.1.40. Used to contain comments associated with any of the data withi... | ||||||||||||
html | ![]() ref
ch-pharm-
|
2018‑01‑11 20:38:46 | 2017 | |||||||||
Reference to Dispense Item | ||||||||||||
html | ![]() ref
ch-pharm-
|
2016‑06‑17 | 2017 | |||||||||
A Dispense Item belongs to one Dispensation and represents one dispensed medication. It contains the dispensed medicinal product including information such as product code, brand name and packaging in... | ||||||||||||
html | ![]() ref
ch-pharm-
|
2016‑09‑13 15:33:18 | 2017 | |||||||||
Dosage Instructions reference to free text (non structured) in narrative part. | ||||||||||||
html | ![]() ref
ch-pharm-
|
2016‑09‑13 16:06:07 | 2017 | |||||||||
Dosage intake mode reference to free text (non structured) in narrative part. | ||||||||||||
html | ![]() ref
IHE-PCC-
|
2013‑12‑20 | 2014 | |||||||||
Allergies and intolerances are special kinds of problems, and so are also recorded in the CDA <observation> element, with classCode='OBS'. They follow the same pattern as the problem... | ||||||||||||
html | ![]() ref
IHE-PCC-
|
2013‑12‑20 | 2014 | |||||||||
html | ![]() ref
IHE-PCC-
|
2016‑09‑28 13:50:21 | 2014 | |||||||||
An Antigen Dose entry is used to record additional details about the patient's immunization history. These entries may be used to provide dose details about a specific antigen received during an Immun... | ||||||||||||
html | ![]() ref
IHE-PCC-
|
2017‑03‑15 13:46:49 | 2016 | |||||||||
The birth event organizer collects observations relevant to a single birth within the patient’s history. This template can be combined with the pregnancy history organizer to organize pregnancy and de... | ||||||||||||
html | ![]() ref
IHE-PCC-
|
2013‑12‑20 | 2014 | |||||||||
This entry allows for a comment to be supplied with each entry. For CDA this structure is usually included in the target act using the <entryRelationship> element defined in the CDA Schema, but can al... | ||||||||||||
html | ![]() ref
ch-pharm-
|
2017‑01‑11 12:32:40 | 2017 | |||||||||
Reference to Dispense Item | ||||||||||||
html | ![]() ref
ch-pharm-
|
2018‑01‑11 11:13:04 | 2017 | |||||||||
A Dispense Item belongs to one Dispensation and represents one dispensed medication. It contains the dispensed medicinal product including information such as product code, brand name and packaging in... | ||||||||||||
html | ![]() ref
IHE-PCC-
|
2013‑12‑20 | 2014 | |||||||||
A problem observation may reference a health status observation. This structure is included in the target observation using the <entryRelationship> element defined in the CDA Schema. The health status... | ||||||||||||
html | ![]() ref
IHE-PCC-
|
2013‑12‑20 | 2014 | |||||||||
html | ![]() ref
IHE-PCC-
|
2013‑12‑20 | 2014 | |||||||||
CDA and HL7 Version 3 Entries may reference (point to) information contained in other entries within the same document | ||||||||||||
html | ![]() ref
IHE-PCC-
|
2013‑12‑20 | 2014 | |||||||||
html | ![]() ref
ch-pharm-
|
2017‑03‑31 14:43:01 | 2017 | |||||||||
A Medication Treatment Plan Item belongs to one medication treatment plan and represents one medication. It may be associated with one or more observations. A Medication Treatment Pl... | ||||||||||||
html | ![]() ref
ch-pharm-
|
2016‑06‑08 | 2017 | |||||||||
IHE PHARM PRE Medicine Entry General Specification | ||||||||||||
html | ![]() ref
ch-pharm-
|
2016‑07‑07 | 2017 | |||||||||
Reference to a Medication Treatment Plan Entry | ||||||||||||
html | ![]() ref
ch-pharm-
|
2017‑10‑11 12:06:00 | 2017 | |||||||||
Reference to Pharmaceutical Advice | ||||||||||||
html | ![]() ref
IHE-PCC-
|
2013‑12‑20 | 2014 | |||||||||
Any medication may be the subject of further instructions to the patient, for example to indicate that it should be taken with food, et cetera. | ||||||||||||
html | ![]() ref
ch-pharm-
|
2018‑01‑11 11:13:04 | 2017 | |||||||||
html | ![]() ref
ch-pharm-
|
2017‑01‑11 11:10:04 | 2017 | |||||||||
Reference to Prescription Item | ||||||||||||
html | ![]() ref
IHE-PCC-
|
2017‑03‑15 14:13:23 | 2016 | |||||||||
The pregnancy history organizer collects observations relevant to a single pregnancy within the patient’s history. The organizer for a pregnancy event shall either contain subordinate birth event orga... | ||||||||||||
html | ![]() ref
IHE-PCC-
|
2016‑10‑21 14:59:35 | 2014 | |||||||||
A pregnancy observation is a Simple Observation that uses a specific vocabulary to record observations about a patient's current or historical pregnancies. | ||||||||||||
html | ![]() ref
ch-pharm-
|
2018‑01‑11 13:04:49 | 2017 | |||||||||
6.3.4.2 Prescription Item Entry Content Module | ||||||||||||
html | ![]() ref
IHE-PCC-
|
2016‑09‑26 08:50:28 | 2014 | |||||||||
This entry is a specialization of the Concern Entry, wherein the subject of the concern is focused on a problem. Elements shown in the example below in gray are explained in the Conc... | ||||||||||||
html | ![]() ref
IHE-PCC-
|
2016‑09‑26 09:50:55 | 2014 | |||||||||
This section makes use of the linking, severity, clinical status and comment content specifications defined elsewhere in the technical framework. In HL7 RIM parlance, observations ab... | ||||||||||||
html | ![]() ref
IHE-PCC-
|
2013‑12‑20 | 2014 | |||||||||
Any problem or allergy observation may reference a problem status observation. This structure is included in the target observation using the <entryRelationship> element defined in ... | ||||||||||||
html | ![]() ref
IHE-PCC-
|
2016‑01‑08 12:51:58 | 2014 | |||||||||
The product entry describes a medication or immunization used in a <substanceAdministration> or <supply> act. It adopts the constraints of the ASTM/HL7 Continuity of Care Document. ... | ||||||||||||
html | ![]() ref
ch-pharm-
|
2018‑01‑11 15:34:25 | 2017 | |||||||||
Renewal Period Content Module describes the possible renewal of a Prescription Item in terms 1985 of duration or period of time (start / end date). | ||||||||||||
html | ![]() ref
IHE-PCC-
|
2013‑12‑20 | 2014 | |||||||||
Any condition or allergy may be the subject of a severity observation. This structure is included in the target act using the <entryRelationship> element defined in the CDA Schema. ... | ||||||||||||
html | ![]() ref
IHE-PCC-
|
2017‑03‑15 09:59:00 | 2016 | |||||||||
This template shall be used when it is necessary to distinguish that a section or entry contained within a CDA document applies to someone other than the patient about whom the docum... | ||||||||||||
html | ![]() ref
ch-pharm-
|
2018‑01‑10 15:34:25 | 2017 | |||||||||
At most one substitution act element MAY be present to inform that a substitution occurred.. | ||||||||||||
html | ![]() ref
ch-pharm-
|
2018‑01‑10 15:34:25 | 2017 | |||||||||
An act element, containing exactly one element describing the substitution permission. | ||||||||||||
html | ![]() ref
IHE-PCC-
|
2013‑12‑20 | 2014 | |||||||||
The supply entry describes a prescription activity. | ||||||||||||
html | ![]() ref
IHE-PCC-
|
2016‑09‑29 09:22:49 | 2014 | |||||||||
A vital signs observation is a simple observation that uses a specific vocabulary, and inherits constraints from CCD. | ||||||||||||
html | ![]() ref
IHE-PCC-
|
2013‑12‑20 | 2014 | |||||||||
A vital signs organizer collects vital signs observations. | ||||||||||||
html | ![]() ref
ch-pharm-
|
2016‑06‑13 | 2017 | |||||||||
A Medicine entry describes a medicine and is used within Medication Treatment- Prescription- or Dispensation Items. It describes either a medicinal product, a generic/scientific name or a magistral pr... | ||||||||||||
html | ![]() ref
ccd1-
|
2007‑04‑01 | ||||||||||
3.9.2.2.4 Medication series number observation The medication series number observation can be used to indicate which in a series of administrations a particular ad... | ||||||||||||
html | ![]() ref
ch-pharm-
|
2016‑06‑13 | 2017 | |||||||||
A medication treatment plan item is an entity describing a medication included in the medication treatment plan of the patient. See also IHE Pharmacy MTP Suppl | ||||||||||||
html | ![]() ref
ch-pharm-
|
2017‑01‑10 15:34:25 | 2017 | |||||||||
Reference to a Medication Treatment Plan Entry | ||||||||||||
html | ![]() ref
ch-pharm-
|
2018‑01‑11 21:10:57 | 2017 | |||||||||
Reference to Pharmaceutical Advice | ||||||||||||
html | ![]() ref
ch-pharm-
|
2016‑01‑11 11:13:04 | 2017 | |||||||||
A Pharmaceutical Advice Concern Item belongs to one Pharmaceutical Advice Item and represents the information to concerns (e.g., problems, allergies, etc.) which the Medication Treatment Plan-, Prescr... | ||||||||||||
html | ![]() ref
ch-pharm-
|
2016‑06‑25 | 2017 | |||||||||
A Pharmaceutical Advice Item belongs to one Pharmaceutical Advice and represents the validation outcome or management command regarding the referenced Medication Treatment Plan-, Prescription- or Disp... | ||||||||||||
html | ![]() ref
ch-pharm-
|
2018‑01‑11 18:31:33 | 2017 | |||||||||
Reference to Prescription Item | ||||||||||||
html | ![]() ref
ch-pharm-
|
2016‑06‑13 | 2017 | |||||||||
Amount of units of the consumable to dispense | ||||||||||||
html | ![]() ref
ch-pharm-
|
2016‑06‑25 | 2017 | |||||||||
A Prescription Item belongs to one prescription and represents one prescribed medication. It may be associated with one or more observations. Prescription Item is the atomic entity for logistics, dist... | ||||||||||||
html | ![]() ref
ch-pharm-
|
2016‑09‑13 17:06:35 | 2017 | |||||||||
Substitution handling for prescriptions | ||||||||||||
html | ![]() ref
ch-pharm-
|
2016‑06‑13 | 2017 | |||||||||
Treatment reason | ||||||||||||
Template type not specified | ||||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||
Address information according to the eCH-0010 V7.0 addressInformation data type. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template by either reference or specialisation. See h... | ||||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||
Reusable template wherever an assigned entity with a required id is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template by either reference or specia... | ||||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||
Reusable template wherever an assigned entity with required id, name, addr, telecom, person and organization are used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY us... | ||||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||
Information about the author of a CDA document, section or entry. An author MAY be a person or a device. All CDA-CH V2 derivatives, i.e. Swiss exchange formats MUST use this template at least in the C... | ||||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||
Reusable template wherever an author with required name, addr and telecom is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template by either reference ... | ||||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||
CDA-CH V2 bases on HL7 CDA R2 (2005) and requires either a nonXMLBody or a StructuredBody. This circumstance is modeled in two separate templates but both MUST contain the same header templates. Ther... | ||||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||
Reusable template wherever a device with required name is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template by either reference or specialisation.... | ||||||||||||
html | ![]() ref
ch-pharm-
|
2017‑01‑23 16:30:55 | 2017 | |||||||||
Dosage Instructions are a set of data elements which together represent the dosage instructions to a medication such as duration of treatment, medication frequency, dose quantity, route of administrat... | ||||||||||||
html | ![]() ref
ch-pharm-
|
2016‑06‑13 | 2017 | |||||||||
Dosage Instructions are a set of data elements which together represent the dosage instructions to a medication such as duration of treatment, medication frequency, dose quantity, route of administrat... | ||||||||||||
html | ![]() |
2018‑01‑08 16:20:12 | 2017 | |||||||||
Header Templates for Medication Card document. | ||||||||||||
html | ![]() |
2018‑01‑08 15:56:47 | 2017 | |||||||||
Header Templates for Medication Dispense document | ||||||||||||
html | ![]() |
2018‑01‑22 15:29:29 | 2017 | |||||||||
Header Templates for Medication List document. | ||||||||||||
html | ![]() |
2018‑01‑08 16:28:39 | 2017 | |||||||||
Header Templates for Medication Prescription | ||||||||||||
html | ![]() |
2018‑01‑08 16:26:11 | 2017 | |||||||||
Header Templates for MedicationTreatmentPlan | ||||||||||||
html | ![]() |
2018‑01‑08 16:23:16 | 2017 | |||||||||
Header Templates for Pharmaceutical Advice document. | ||||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||
Reusable template wherever a text reference to the corresponding text in the human readable part (narrative text) is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MA... | ||||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||
Reusable template wherever an organization with required GLN as id and name is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template by either referenc... | ||||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||
Reusable template wherever an organization with required GLN as id, name, address and communication means is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use th... | ||||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||
Reusable template wherever an organization with required id, name, address and communication means is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this temp... | ||||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||
Reusable template wherever an organization with required name is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template by either reference or specialis... | ||||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||
Reusable template wherever an organization with required name, address and communication means is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template... | ||||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||
Reusable template wherever a original text reference to the corresponding text in the human readable part (narrative text) is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange f... | ||||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||
Reusable template wherever a healthcare provider who was the primary performer of an act is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template by ei... | ||||||||||||
html | ![]() ref
hl7chcda-
|
2018‑04‑18 | 2017 | |||||||||
Person name information (with required family and given name) according to the eCH-0011 V8.1 nameData data type. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template by either ref... |
Templates | 147 |
Transaction | Representing template | Link | as of |
---|---|---|---|
Medication Treatment Plan document | chdachpharm-template-document-7 | Medication Treatment Plan document | 2017‑04‑12 13:57:31 |
Medication Prescription document | chdachpharm-template-document-4 | Medication Prescription document | 2016‑05‑21 |
Medication Dispense document | chdachpharm-template-document-5 | Medication Dispense document | 2016‑05‑21 |
Pharmaceutical Advice document | chdachpharm-template-document-6 | Pharmaceutical Advice document | 2016‑05‑21 |
Medication List document | chdachpharm-template-document-13 | Medication List document | 2018‑01‑22 15:17:26 |
Medication Card document | chdachpharm-template-document-3 | Medication Card document | 2016‑05‑13 |
Label | Template id | Template name | Link | as of | |
---|---|---|---|---|---|
6.3.1.1 | ![]() |
1.3.6.1.4.1.19376.1.9.1.1.1 | IHE Community Prescription Content Module | 1.3.6.1.4.1.19376.1.9.1.1.1 | 2018‑01‑17 16:46:48 |
6.3.1.1.2 | ![]() |
1.3.6.1.4.1.19376.1.9.1.1.1 | IHE Community Prescription Content Module | 1.3.6.1.4.1.19376.1.9.1.1.1 | 2018‑01‑17 16:46:48 |
6.3.1.1.2 | ![]() |
1.3.6.1.4.1.19376.1.9.1.1.2 | IHE Pharmacy Pharmaceutical Advice Document Content Module | 1.3.6.1.4.1.19376.1.9.1.1.2 | 2018‑01‑17 17:57:48 |
6.3.1.1.5 | ![]() |
1.3.6.1.4.1.19376.1.9.1.1.1 | IHE Community Prescription Content Module | 1.3.6.1.4.1.19376.1.9.1.1.1 | 2018‑01‑17 16:46:48 |
6.3.1.1.5 | ![]() |
1.3.6.1.4.1.19376.1.9.1.1.1 | IHE Community Prescription Content Module | 1.3.6.1.4.1.19376.1.9.1.1.1 | 2018‑01‑17 16:46:48 |
6.3.1.1.5 | ![]() |
1.3.6.1.4.1.19376.1.9.1.1.1 | IHE Community Prescription Content Module | 1.3.6.1.4.1.19376.1.9.1.1.1 | 2018‑01‑17 16:46:48 |
6.3.1.1.5 | ![]() |
1.3.6.1.4.1.19376.1.9.1.1.1 | IHE Community Prescription Content Module | 1.3.6.1.4.1.19376.1.9.1.1.1 | 2018‑01‑17 16:46:48 |
6.3.1.1.5 | ![]() |
1.3.6.1.4.1.19376.1.9.1.1.1 | IHE Community Prescription Content Module | 1.3.6.1.4.1.19376.1.9.1.1.1 | 2018‑01‑17 16:46:48 |
6.3.1.1.5 | ![]() |
1.3.6.1.4.1.19376.1.9.1.1.1 | IHE Community Prescription Content Module | 1.3.6.1.4.1.19376.1.9.1.1.1 | 2018‑01‑17 16:46:48 |
6.3.1.1.5 | ![]() |
1.3.6.1.4.1.19376.1.9.1.1.1 | IHE Community Prescription Content Module | 1.3.6.1.4.1.19376.1.9.1.1.1 | 2018‑01‑17 16:46:48 |
6.3.1.1.5 | ![]() |
1.3.6.1.4.1.19376.1.9.1.1.1 | IHE Community Prescription Content Module | 1.3.6.1.4.1.19376.1.9.1.1.1 | 2018‑01‑17 16:46:48 |
6.3.1.1.5 | ![]() |
1.3.6.1.4.1.19376.1.9.1.1.1 | IHE Community Prescription Content Module | 1.3.6.1.4.1.19376.1.9.1.1.1 | 2018‑01‑17 16:46:48 |
6.3.1.1.5 | ![]() |
1.3.6.1.4.1.19376.1.9.1.1.2 | IHE Pharmacy Pharmaceutical Advice Document Content Module | 1.3.6.1.4.1.19376.1.9.1.1.2 | 2018‑01‑17 17:57:48 |
6.3.1.1.5 | ![]() |
1.3.6.1.4.1.19376.1.9.1.1.2 | IHE Pharmacy Pharmaceutical Advice Document Content Module | 1.3.6.1.4.1.19376.1.9.1.1.2 | 2018‑01‑17 17:57:48 |
6.3.1.2 | ![]() |
1.3.6.1.4.1.19376.1.9.1.1.2 | IHE Pharmacy Pharmaceutical Advice Document Content Module | 1.3.6.1.4.1.19376.1.9.1.1.2 | 2018‑01‑17 17:57:48 |
6.3.1.2.2 | ![]() |
1.3.6.1.4.1.19376.1.9.1.1.2 | IHE Pharmacy Pharmaceutical Advice Document Content Module | 1.3.6.1.4.1.19376.1.9.1.1.2 | 2018‑01‑17 17:57:48 |
6.3.1.3 | ![]() |
1.3.6.1.4.1.19376.1.9.1.1.3 | IHE Pharmacy Dispense Document Content Module | 1.3.6.1.4.1.19376.1.9.1.1.3 | 2018‑01‑17 17:47:52 |
6.3.1.3 | ![]() |
1.3.6.1.4.1.19376.1.9.1.1.3 | IHE Pharmacy Dispense Document Content Module | 1.3.6.1.4.1.19376.1.9.1.1.3 | 2018‑01‑17 17:47:52 |
6.3.1.3.2 | ![]() |
1.3.6.1.4.1.19376.1.9.1.1.3 | IHE Pharmacy Dispense Document Content Module | 1.3.6.1.4.1.19376.1.9.1.1.3 | 2018‑01‑17 17:47:52 |
6.3.1.3.5 | ![]() |
1.3.6.1.4.1.19376.1.9.1.1.3 | IHE Pharmacy Dispense Document Content Module | 1.3.6.1.4.1.19376.1.9.1.1.3 | 2018‑01‑17 17:47:52 |
6.3.1.3.5 | ![]() |
1.3.6.1.4.1.19376.1.9.1.1.3 | IHE Pharmacy Dispense Document Content Module | 1.3.6.1.4.1.19376.1.9.1.1.3 | 2018‑01‑17 17:47:52 |
6.3.1.D.5 | ![]() |
1.3.6.1.4.1.19376.1.9.1.1.5 | IHE Pharmacy Medication List | 1.3.6.1.4.1.19376.1.9.1.1.5 | 2018‑01‑17 18:06:02 |
6.3.2.1 | ![]() |
1.3.6.1.4.1.19376.1.9.1.1.1 | IHE Community Prescription Content Module | 1.3.6.1.4.1.19376.1.9.1.1.1 | 2018‑01‑17 16:46:48 |
6.3.2.1 | ![]() |
chdachpharm-template-other-45 | Header Template Compilation Medication Prescription document | 2.16.756.5.30.1.1.10.9.45 | 2018‑01‑08 16:28:39 |
6.3.3.1 | ![]() |
1.3.6.1.4.1.19376.1.9.1.2.1 | IHE Prescription Section Content Module | 1.3.6.1.4.1.19376.1.9.1.2.1 | 2018‑01‑10 11:13:04 |
6.3.3.1 | ![]() |
1.3.6.1.4.1.19376.1.9.1.2.1 | IHE Prescription Section Content Module | 1.3.6.1.4.1.19376.1.9.1.2.1 | 2018‑01‑10 11:13:04 |
6.3.3.1 | ![]() |
1.3.6.1.4.1.19376.1.9.1.2.1 | IHE Prescription Section Content Module | 1.3.6.1.4.1.19376.1.9.1.2.1 | 2018‑01‑10 11:13:04 |
6.3.3.1 | ![]() |
1.3.6.1.4.1.19376.1.9.1.2.2 | IHE Pharmaceutical Advice Section Content Moudule | 1.3.6.1.4.1.19376.1.9.1.2.2 | 2018‑01‑10 11:13:04 |
6.3.3.1.2 | ![]() |
1.3.6.1.4.1.19376.1.9.1.2.1 | IHE Prescription Section Content Module | 1.3.6.1.4.1.19376.1.9.1.2.1 | 2018‑01‑10 11:13:04 |
6.3.3.10.S | ![]() |
1.3.6.1.4.1.19376.1.9.1.2.5 | IHE Medication List Section Content Module | 1.3.6.1.4.1.19376.1.9.1.2.5 | 2018‑01‑10 08:39:19 |
6.3.3.10.S1 | ![]() |
1.3.6.1.4.1.19376.1.9.1.2.6 | IHE Medication Treatment Plan Section Content Module | 1.3.6.1.4.1.19376.1.9.1.2.6 | 2017‑04‑03 07:47:01 |
6.3.3.10.S1 | ![]() |
chdachpharm-template-section-13 | Medication Treatment Plan Section Content Module | 2.16.756.5.30.1.1.10.3.13 | 2017‑05‑01 12:51:36 |
6.3.3.2 | ![]() |
1.3.6.1.4.1.19376.1.9.1.2.2 | IHE Pharmaceutical Advice Section Content Moudule | 1.3.6.1.4.1.19376.1.9.1.2.2 | 2018‑01‑10 11:13:04 |
6.3.3.2 | ![]() |
1.3.6.1.4.1.19376.1.9.1.2.2 | IHE Pharmaceutical Advice Section Content Moudule | 1.3.6.1.4.1.19376.1.9.1.2.2 | 2018‑01‑10 11:13:04 |
6.3.3.2.11 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.3.13 | IHE Allergies and Other Adverse Reactions Section | 1.3.6.1.4.1.19376.1.5.3.1.3.13 | 2013‑12‑20 |
6.3.3.2.18 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.1.5.3.4 | IHE Pregnancy History Section | 1.3.6.1.4.1.19376.1.5.3.1.1.5.3.4 | 2017‑03‑20 13:38:42 |
6.3.3.2.2 | ![]() |
1.3.6.1.4.1.19376.1.9.1.2.2 | IHE Pharmaceutical Advice Section Content Moudule | 1.3.6.1.4.1.19376.1.9.1.2.2 | 2018‑01‑10 11:13:04 |
6.3.3.2.3 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.3.6 | IHE Active Problems Section | 1.3.6.1.4.1.19376.1.5.3.1.3.6 | 2015‑10‑05 16:02:07 |
6.3.3.2.5 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.3.8 | IHE History of Past Illness Section | 1.3.6.1.4.1.19376.1.5.3.1.3.8 | 2013‑12‑20 |
6.3.3.3 | ![]() |
1.3.6.1.4.1.19376.1.9.1.2.3 | IHE Dispense Section Content Module | 1.3.6.1.4.1.19376.1.9.1.2.3 | 2018‑01‑10 11:13:04 |
6.3.3.3 | ![]() |
1.3.6.1.4.1.19376.1.9.1.2.3 | IHE Dispense Section Content Module | 1.3.6.1.4.1.19376.1.9.1.2.3 | 2018‑01‑10 11:13:04 |
6.3.3.3 | ![]() |
1.3.6.1.4.1.19376.1.9.1.2.3 | IHE Dispense Section Content Module | 1.3.6.1.4.1.19376.1.9.1.2.3 | 2018‑01‑10 11:13:04 |
6.3.3.3.2 | ![]() |
1.3.6.1.4.1.19376.1.9.1.2.3 | IHE Dispense Section Content Module | 1.3.6.1.4.1.19376.1.9.1.2.3 | 2018‑01‑10 11:13:04 |
6.3.3.3.5 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.3.23 | IHE Immunizations Section | 1.3.6.1.4.1.19376.1.5.3.1.3.23 | 2013‑12‑20 |
6.3.3.4.5 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.1.5.3.2 | IHE Coded Vital Signs Section | 1.3.6.1.4.1.19376.1.5.3.1.1.5.3.2 | 2015‑10‑05 15:57:07 |
6.3.4.1.3.1 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.1 | IHE MedicineEntryContentModule | 1.3.6.1.4.1.19376.1.9.1.3.1 | 2016‑06‑08 |
6.3.4.1.3.1 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.2 | IHE Prescription Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.2 | 2018‑01‑11 13:04:49 |
6.3.4.1.3.1 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.2 | IHE Prescription Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.2 | 2018‑01‑11 13:04:49 |
6.3.4.1.3.1 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.4 | IHE Dispense Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.4 | 2018‑01‑11 11:13:04 |
6.3.4.1.3.1 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.4 | IHE Dispense Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.4 | 2018‑01‑11 11:13:04 |
6.3.4.1.3.1 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.7 | IHE Medication Treatment Plan Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.7 | 2017‑03‑31 14:43:01 |
6.3.4.1.3.1 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.7 | IHE Medication Treatment Plan Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.7 | 2017‑03‑31 14:43:01 |
6.3.4.1.3.1 | ![]() |
chdachpharm-template-entry-34 | Medication Treatment Plan Item Entry Content Module | 2.16.756.5.30.1.1.10.4.34 | 2016‑06‑13 |
6.3.4.1.3.1 | ![]() |
chdachpharm-template-entry-34 | Medication Treatment Plan Item Entry Content Module | 2.16.756.5.30.1.1.10.4.34 | 2016‑06‑13 |
6.3.4.1.3.1 | ![]() |
chdachpharm-template-entry-42 | Dispense Item Entry Content Module | 2.16.756.5.30.1.1.10.4.42 | 2016‑06‑17 |
6.3.4.1.3.1 | ![]() |
chdachpharm-template-entry-42 | Dispense Item Entry Content Module | 2.16.756.5.30.1.1.10.4.42 | 2016‑06‑17 |
6.3.4.1.3.1 | ![]() |
chdachpharm-template-entry-43 | Prescription Item Entry Content Module | 2.16.756.5.30.1.1.10.4.43 | 2016‑06‑25 |
6.3.4.1.3.1 | ![]() |
chdachpharm-template-entry-43 | Prescription Item Entry Content Module | 2.16.756.5.30.1.1.10.4.43 | 2016‑06‑25 |
6.3.4.1.3.10 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.1 | IHE MedicineEntryContentModule | 1.3.6.1.4.1.19376.1.9.1.3.1 | 2016‑06‑08 |
6.3.4.1.3.2 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.1 | IHE MedicineEntryContentModule | 1.3.6.1.4.1.19376.1.9.1.3.1 | 2016‑06‑08 |
6.3.4.1.3.3 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.1 | IHE MedicineEntryContentModule | 1.3.6.1.4.1.19376.1.9.1.3.1 | 2016‑06‑08 |
6.3.4.1.3.4 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.1 | IHE MedicineEntryContentModule | 1.3.6.1.4.1.19376.1.9.1.3.1 | 2016‑06‑08 |
6.3.4.1.3.5 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.1 | IHE MedicineEntryContentModule | 1.3.6.1.4.1.19376.1.9.1.3.1 | 2016‑06‑08 |
6.3.4.1.3.6 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.1 | IHE MedicineEntryContentModule | 1.3.6.1.4.1.19376.1.9.1.3.1 | 2016‑06‑08 |
6.3.4.1.3.7 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.1 | IHE MedicineEntryContentModule | 1.3.6.1.4.1.19376.1.9.1.3.1 | 2016‑06‑08 |
6.3.4.1.3.8 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.1 | IHE MedicineEntryContentModule | 1.3.6.1.4.1.19376.1.9.1.3.1 | 2016‑06‑08 |
6.3.4.1.3.9 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.1 | IHE MedicineEntryContentModule | 1.3.6.1.4.1.19376.1.9.1.3.1 | 2016‑06‑08 |
6.3.4.10 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.4.1 | IHE Internal Reference Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.4.1 | 2013‑12‑20 |
6.3.4.10.3.1 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.11 | IHE PRE Reference Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.11 | 2017‑01‑11 11:10:04 |
6.3.4.10.3.1 | ![]() |
chdachpharm-template-entry-47 | PRE Reference Entry Content Module | 2.16.756.5.30.1.1.10.4.47 | 2018‑01‑11 18:31:33 |
6.3.4.10.3.2 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.11 | IHE PRE Reference Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.11 | 2017‑01‑11 11:10:04 |
6.3.4.10.3.2 | ![]() |
chdachpharm-template-entry-47 | PRE Reference Entry Content Module | 2.16.756.5.30.1.1.10.4.47 | 2018‑01‑11 18:31:33 |
6.3.4.10.3.3 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.11 | IHE PRE Reference Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.11 | 2017‑01‑11 11:10:04 |
6.3.4.10.3.3 | ![]() |
chdachpharm-template-entry-47 | PRE Reference Entry Content Module | 2.16.756.5.30.1.1.10.4.47 | 2018‑01‑11 18:31:33 |
6.3.4.10.3.4 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.11 | IHE PRE Reference Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.11 | 2017‑01‑11 11:10:04 |
6.3.4.10.3.4 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.11 | IHE PRE Reference Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.11 | 2017‑01‑11 11:10:04 |
6.3.4.10.3.4 | ![]() |
chdachpharm-template-entry-47 | PRE Reference Entry Content Module | 2.16.756.5.30.1.1.10.4.47 | 2018‑01‑11 18:31:33 |
6.3.4.10.3.4 | ![]() |
chdachpharm-template-entry-47 | PRE Reference Entry Content Module | 2.16.756.5.30.1.1.10.4.47 | 2018‑01‑11 18:31:33 |
6.3.4.10.3.6 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.11 | IHE PRE Reference Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.11 | 2017‑01‑11 11:10:04 |
6.3.4.10.3.7 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.11 | IHE PRE Reference Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.11 | 2017‑01‑11 11:10:04 |
6.3.4.10.3.7 | ![]() |
chdachpharm-template-entry-47 | PRE Reference Entry Content Module | 2.16.756.5.30.1.1.10.4.47 | 2018‑01‑11 18:31:33 |
6.3.4.10.4 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.4.1 | IHE Internal Reference Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.4.1 | 2013‑12‑20 |
6.3.4.10.5 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.4.1 | IHE Internal Reference Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.4.1 | 2013‑12‑20 |
6.3.4.10.6 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.4.1 | IHE Internal Reference Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.4.1 | 2013‑12‑20 |
6.3.4.11.10 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.5.2 | IHE Problem Concern Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.5.2 | 2016‑09‑26 08:50:28 |
6.3.4.11.3.1 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.12 | IHE DIS Reference Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.12 | 2017‑01‑11 12:32:40 |
6.3.4.11.3.1 | ![]() |
chdachpharm-template-entry-46 | DIS Reference Entry Content Module | 2.16.756.5.30.1.1.10.4.46 | 2018‑01‑11 20:38:46 |
6.3.4.11.3.2 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.12 | IHE DIS Reference Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.12 | 2017‑01‑11 12:32:40 |
6.3.4.11.3.2 | ![]() |
chdachpharm-template-entry-46 | DIS Reference Entry Content Module | 2.16.756.5.30.1.1.10.4.46 | 2018‑01‑11 20:38:46 |
6.3.4.11.3.3 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.12 | IHE DIS Reference Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.12 | 2017‑01‑11 12:32:40 |
6.3.4.11.3.3 | ![]() |
chdachpharm-template-entry-46 | DIS Reference Entry Content Module | 2.16.756.5.30.1.1.10.4.46 | 2018‑01‑11 20:38:46 |
6.3.4.11.3.4 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.12 | IHE DIS Reference Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.12 | 2017‑01‑11 12:32:40 |
6.3.4.11.3.4 | ![]() |
chdachpharm-template-entry-46 | DIS Reference Entry Content Module | 2.16.756.5.30.1.1.10.4.46 | 2018‑01‑11 20:38:46 |
6.3.4.11.3.5 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.12 | IHE DIS Reference Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.12 | 2017‑01‑11 12:32:40 |
6.3.4.11.3.5 | ![]() |
chdachpharm-template-entry-46 | DIS Reference Entry Content Module | 2.16.756.5.30.1.1.10.4.46 | 2018‑01‑11 20:38:46 |
6.3.4.11.3.6 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.12 | IHE DIS Reference Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.12 | 2017‑01‑11 12:32:40 |
6.3.4.11.3.7 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.12 | IHE DIS Reference Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.12 | 2017‑01‑11 12:32:40 |
6.3.4.11.3.7 | ![]() |
chdachpharm-template-entry-46 | DIS Reference Entry Content Module | 2.16.756.5.30.1.1.10.4.46 | 2018‑01‑11 20:38:46 |
6.3.4.11.5 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.5.2 | IHE Problem Concern Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.5.2 | 2016‑09‑26 08:50:28 |
6.3.4.11.6 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.5.2 | IHE Problem Concern Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.5.2 | 2016‑09‑26 08:50:28 |
6.3.4.11.9 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.5.2 | IHE Problem Concern Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.5.2 | 2016‑09‑26 08:50:28 |
6.3.4.12 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.5.2 | IHE Problem Concern Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.5.2 | 2016‑09‑26 08:50:28 |
6.3.4.12.3.1 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.13 | IHE PADV Reference Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.13 | 2017‑10‑11 12:06:00 |
6.3.4.12.3.1 | ![]() |
chdachpharm-template-entry-53 | PADV Reference Entry Content Module | 2.16.756.5.30.1.1.10.4.53 | 2018‑01‑11 21:10:57 |
6.3.4.12.3.2 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.13 | IHE PADV Reference Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.13 | 2017‑10‑11 12:06:00 |
6.3.4.12.3.2 | ![]() |
chdachpharm-template-entry-53 | PADV Reference Entry Content Module | 2.16.756.5.30.1.1.10.4.53 | 2018‑01‑11 21:10:57 |
6.3.4.12.3.3 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.13 | IHE PADV Reference Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.13 | 2017‑10‑11 12:06:00 |
6.3.4.12.3.3 | ![]() |
chdachpharm-template-entry-53 | PADV Reference Entry Content Module | 2.16.756.5.30.1.1.10.4.53 | 2018‑01‑11 21:10:57 |
6.3.4.12.3.4 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.13 | IHE PADV Reference Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.13 | 2017‑10‑11 12:06:00 |
6.3.4.12.3.4 | ![]() |
chdachpharm-template-entry-53 | PADV Reference Entry Content Module | 2.16.756.5.30.1.1.10.4.53 | 2018‑01‑11 21:10:57 |
6.3.4.12.3.5 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.13 | IHE PADV Reference Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.13 | 2017‑10‑11 12:06:00 |
6.3.4.12.3.5 | ![]() |
chdachpharm-template-entry-53 | PADV Reference Entry Content Module | 2.16.756.5.30.1.1.10.4.53 | 2018‑01‑11 21:10:57 |
6.3.4.12.3.6 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.13 | IHE PADV Reference Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.13 | 2017‑10‑11 12:06:00 |
6.3.4.12.3.7 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.13 | IHE PADV Reference Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.13 | 2017‑10‑11 12:06:00 |
6.3.4.12.3.7 | ![]() |
chdachpharm-template-entry-53 | PADV Reference Entry Content Module | 2.16.756.5.30.1.1.10.4.53 | 2018‑01‑11 21:10:57 |
6.3.4.12.4 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.5.2 | IHE Problem Concern Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.5.2 | 2016‑09‑26 08:50:28 |
6.3.4.12.4 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.5.2 | IHE Problem Concern Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.5.2 | 2016‑09‑26 08:50:28 |
6.3.4.12.4 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.5.2 | IHE Problem Concern Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.5.2 | 2016‑09‑26 08:50:28 |
6.3.4.13 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.5.3 | IHE Allergy and Intolerance Concern Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.5.3 | 2013‑12‑20 |
6.3.4.13.4 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.5.3 | IHE Allergy and Intolerance Concern Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.5.3 | 2013‑12‑20 |
6.3.4.13.4 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.5.3 | IHE Allergy and Intolerance Concern Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.5.3 | 2013‑12‑20 |
6.3.4.13.4 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.5.3 | IHE Allergy and Intolerance Concern Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.5.3 | 2013‑12‑20 |
6.3.4.14 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.5 | IHE Problem Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.5 | 2016‑09‑26 09:50:55 |
6.3.4.14 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.15 | IHE Renewal Period Content Module | 1.3.6.1.4.1.19376.1.9.1.3.15 | 2018‑01‑11 15:34:25 |
6.3.4.14.2.1 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.15 | IHE Renewal Period Content Module | 1.3.6.1.4.1.19376.1.9.1.3.15 | 2018‑01‑11 15:34:25 |
6.3.4.14.2.2 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.15 | IHE Renewal Period Content Module | 1.3.6.1.4.1.19376.1.9.1.3.15 | 2018‑01‑11 15:34:25 |
6.3.4.14.2.3 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.15 | IHE Renewal Period Content Module | 1.3.6.1.4.1.19376.1.9.1.3.15 | 2018‑01‑11 15:34:25 |
6.3.4.15 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.6 | IHE Allergies And Intolerances Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.6 | 2013‑12‑20 |
6.3.4.17 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.12 | IHE Immunizations Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.12 | 2013‑12‑20 |
6.3.4.17.10 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.12 | IHE Immunizations Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.12 | 2013‑12‑20 |
6.3.4.17.11 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.12 | IHE Immunizations Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.12 | 2013‑12‑20 |
6.3.4.17.12 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.12 | IHE Immunizations Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.12 | 2013‑12‑20 |
6.3.4.17.13 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.12 | IHE Immunizations Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.12 | 2013‑12‑20 |
6.3.4.17.14 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.12 | IHE Immunizations Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.12 | 2013‑12‑20 |
6.3.4.17.18 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.12 | IHE Immunizations Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.12 | 2013‑12‑20 |
6.3.4.17.22 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.12 | IHE Immunizations Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.12 | 2013‑12‑20 |
6.3.4.17.3 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.12 | IHE Immunizations Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.12 | 2013‑12‑20 |
6.3.4.17.3 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.12 | IHE Immunizations Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.12 | 2013‑12‑20 |
6.3.4.17.4 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.12 | IHE Immunizations Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.12 | 2013‑12‑20 |
6.3.4.17.5 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.12 | IHE Immunizations Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.12 | 2013‑12‑20 |
6.3.4.17.6 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.12 | IHE Immunizations Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.12 | 2013‑12‑20 |
6.3.4.17.7 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.12 | IHE Immunizations Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.12 | 2013‑12‑20 |
6.3.4.17.8 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.12 | IHE Immunizations Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.12 | 2013‑12‑20 |
6.3.4.17.9 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.12 | IHE Immunizations Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.12 | 2013‑12‑20 |
6.3.4.18 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.7.3 | IHE Supply Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.7.3 | 2013‑12‑20 |
6.3.4.18.10 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.7.3 | IHE Supply Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.7.3 | 2013‑12‑20 |
6.3.4.18.11 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.7.3 | IHE Supply Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.7.3 | 2013‑12‑20 |
6.3.4.18.12 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.7.3 | IHE Supply Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.7.3 | 2013‑12‑20 |
6.3.4.18.13 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.7.3 | IHE Supply Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.7.3 | 2013‑12‑20 |
6.3.4.18.14 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.7.3 | IHE Supply Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.7.3 | 2013‑12‑20 |
6.3.4.18.15 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.7.3 | IHE Supply Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.7.3 | 2013‑12‑20 |
6.3.4.18.16 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.7.3 | IHE Supply Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.7.3 | 2013‑12‑20 |
6.3.4.18.17 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.7.3 | IHE Supply Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.7.3 | 2013‑12‑20 |
6.3.4.18.18 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.7.3 | IHE Supply Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.7.3 | 2013‑12‑20 |
6.3.4.18.19 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.7.3 | IHE Supply Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.7.3 | 2013‑12‑20 |
6.3.4.18.4 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.7.3 | IHE Supply Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.7.3 | 2013‑12‑20 |
6.3.4.18.5 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.7.3 | IHE Supply Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.7.3 | 2013‑12‑20 |
6.3.4.18.5 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.7.3 | IHE Supply Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.7.3 | 2013‑12‑20 |
6.3.4.18.6 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.7.3 | IHE Supply Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.7.3 | 2013‑12‑20 |
6.3.4.18.7 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.7.3 | IHE Supply Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.7.3 | 2013‑12‑20 |
6.3.4.18.8 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.7.3 | IHE Supply Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.7.3 | 2013‑12‑20 |
6.3.4.18.9 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.7.3 | IHE Supply Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.7.3 | 2013‑12‑20 |
6.3.4.19 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.7.2 | IHE Product Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.7.2 | 2016‑01‑08 12:51:58 |
6.3.4.19.2 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.7.2 | IHE Product Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.7.2 | 2016‑01‑08 12:51:58 |
6.3.4.19.2 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.7.2 | IHE Product Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.7.2 | 2016‑01‑08 12:51:58 |
6.3.4.19.3 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.7.2 | IHE Product Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.7.2 | 2016‑01‑08 12:51:58 |
6.3.4.2 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.2 | IHE Prescription Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.2 | 2018‑01‑11 13:04:49 |
6.3.4.2.3.1 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.2 | IHE Prescription Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.2 | 2018‑01‑11 13:04:49 |
6.3.4.2.3.10 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.2 | IHE Prescription Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.2 | 2018‑01‑11 13:04:49 |
6.3.4.2.3.10 | ![]() |
chdachpharm-template-entry-43 | Prescription Item Entry Content Module | 2.16.756.5.30.1.1.10.4.43 | 2016‑06‑25 |
6.3.4.2.3.11 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.2 | IHE Prescription Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.2 | 2018‑01‑11 13:04:49 |
6.3.4.2.3.11 | ![]() |
chdachpharm-template-entry-43 | Prescription Item Entry Content Module | 2.16.756.5.30.1.1.10.4.43 | 2016‑06‑25 |
6.3.4.2.3.12 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.2 | IHE Prescription Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.2 | 2018‑01‑11 13:04:49 |
6.3.4.2.3.12 | ![]() |
chdachpharm-template-entry-43 | Prescription Item Entry Content Module | 2.16.756.5.30.1.1.10.4.43 | 2016‑06‑25 |
6.3.4.2.3.13 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.2 | IHE Prescription Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.2 | 2018‑01‑11 13:04:49 |
6.3.4.2.3.14 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.2 | IHE Prescription Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.2 | 2018‑01‑11 13:04:49 |
6.3.4.2.3.14 | ![]() |
chdachpharm-template-entry-43 | Prescription Item Entry Content Module | 2.16.756.5.30.1.1.10.4.43 | 2016‑06‑25 |
6.3.4.2.3.15 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.4 | IHE Dispense Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.4 | 2018‑01‑11 11:13:04 |
6.3.4.2.3.15 | ![]() |
chdachpharm-template-entry-42 | Dispense Item Entry Content Module | 2.16.756.5.30.1.1.10.4.42 | 2016‑06‑17 |
6.3.4.2.3.16 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.2 | IHE Prescription Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.2 | 2018‑01‑11 13:04:49 |
6.3.4.2.3.16 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.4 | IHE Dispense Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.4 | 2018‑01‑11 11:13:04 |
6.3.4.2.3.16 | ![]() |
chdachpharm-template-entry-42 | Dispense Item Entry Content Module | 2.16.756.5.30.1.1.10.4.42 | 2016‑06‑17 |
6.3.4.2.3.17 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.2 | IHE Prescription Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.2 | 2018‑01‑11 13:04:49 |
6.3.4.2.3.17 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.4 | IHE Dispense Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.4 | 2018‑01‑11 11:13:04 |
6.3.4.2.3.17 | ![]() |
chdachpharm-template-entry-42 | Dispense Item Entry Content Module | 2.16.756.5.30.1.1.10.4.42 | 2016‑06‑17 |
6.3.4.2.3.17 | ![]() |
chdachpharm-template-entry-43 | Prescription Item Entry Content Module | 2.16.756.5.30.1.1.10.4.43 | 2016‑06‑25 |
6.3.4.2.3.18 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.2 | IHE Prescription Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.2 | 2018‑01‑11 13:04:49 |
6.3.4.2.3.18 | ![]() |
chdachpharm-template-entry-43 | Prescription Item Entry Content Module | 2.16.756.5.30.1.1.10.4.43 | 2016‑06‑25 |
6.3.4.2.3.19 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.2 | IHE Prescription Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.2 | 2018‑01‑11 13:04:49 |
6.3.4.2.3.19 | ![]() |
chdachpharm-template-entry-43 | Prescription Item Entry Content Module | 2.16.756.5.30.1.1.10.4.43 | 2016‑06‑25 |
6.3.4.2.3.2 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.2 | IHE Prescription Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.2 | 2018‑01‑11 13:04:49 |
6.3.4.2.3.2 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.2 | IHE Prescription Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.2 | 2018‑01‑11 13:04:49 |
6.3.4.2.3.2 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.2 | IHE Prescription Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.2 | 2018‑01‑11 13:04:49 |
6.3.4.2.3.2 | ![]() |
chdachpharm-template-entry-43 | Prescription Item Entry Content Module | 2.16.756.5.30.1.1.10.4.43 | 2016‑06‑25 |
6.3.4.2.3.20 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.2 | IHE Prescription Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.2 | 2018‑01‑11 13:04:49 |
6.3.4.2.3.20 | ![]() |
chdachpharm-template-entry-43 | Prescription Item Entry Content Module | 2.16.756.5.30.1.1.10.4.43 | 2016‑06‑25 |
6.3.4.2.3.21 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.2 | IHE Prescription Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.2 | 2018‑01‑11 13:04:49 |
6.3.4.2.3.21 | ![]() |
chdachpharm-template-entry-43 | Prescription Item Entry Content Module | 2.16.756.5.30.1.1.10.4.43 | 2016‑06‑25 |
6.3.4.2.3.22 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.2 | IHE Prescription Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.2 | 2018‑01‑11 13:04:49 |
6.3.4.2.3.22 | ![]() |
chdachpharm-template-entry-43 | Prescription Item Entry Content Module | 2.16.756.5.30.1.1.10.4.43 | 2016‑06‑25 |
6.3.4.2.3.3 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.2 | IHE Prescription Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.2 | 2018‑01‑11 13:04:49 |
6.3.4.2.3.3 | ![]() |
chdachpharm-template-entry-43 | Prescription Item Entry Content Module | 2.16.756.5.30.1.1.10.4.43 | 2016‑06‑25 |
6.3.4.2.3.3 | ![]() |
chdachpharm-template-entry-43 | Prescription Item Entry Content Module | 2.16.756.5.30.1.1.10.4.43 | 2016‑06‑25 |
6.3.4.2.3.4 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.2 | IHE Prescription Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.2 | 2018‑01‑11 13:04:49 |
6.3.4.2.3.5 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.2 | IHE Prescription Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.2 | 2018‑01‑11 13:04:49 |
6.3.4.2.3.6 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.2 | IHE Prescription Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.2 | 2018‑01‑11 13:04:49 |
6.3.4.2.3.6 | ![]() |
chdachpharm-template-entry-43 | Prescription Item Entry Content Module | 2.16.756.5.30.1.1.10.4.43 | 2016‑06‑25 |
6.3.4.2.3.7 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.2 | IHE Prescription Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.2 | 2018‑01‑11 13:04:49 |
6.3.4.2.3.7 | ![]() |
chdachpharm-template-entry-43 | Prescription Item Entry Content Module | 2.16.756.5.30.1.1.10.4.43 | 2016‑06‑25 |
6.3.4.2.3.8 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.2 | IHE Prescription Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.2 | 2018‑01‑11 13:04:49 |
6.3.4.2.3.8 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.2 | IHE Prescription Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.2 | 2018‑01‑11 13:04:49 |
6.3.4.2.3.8 | ![]() |
chdachpharm-template-entry-35 | Dosage Instructions Start/Stop, Frequency, Dose | 2.16.756.5.30.1.1.10.4.35 | 2016‑06‑13 |
6.3.4.2.3.8 | ![]() |
chdachpharm-template-entry-35 | Dosage Instructions Start/Stop, Frequency, Dose | 2.16.756.5.30.1.1.10.4.35 | 2016‑06‑13 |
6.3.4.2.3.8 | ![]() |
chdachpharm-template-entry-35 | Dosage Instructions Start/Stop, Frequency, Dose | 2.16.756.5.30.1.1.10.4.35 | 2016‑06‑13 |
6.3.4.2.3.9 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.2 | IHE Prescription Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.2 | 2018‑01‑11 13:04:49 |
6.3.4.2.3.9 | ![]() |
chdachpharm-template-entry-43 | Prescription Item Entry Content Module | 2.16.756.5.30.1.1.10.4.43 | 2016‑06‑25 |
6.3.4.21 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.13.1 | IHE Vital Signs Organizer | 1.3.6.1.4.1.19376.1.5.3.1.4.13.1 | 2013‑12‑20 |
6.3.4.21.3 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.13.1 | IHE Vital Signs Organizer | 1.3.6.1.4.1.19376.1.5.3.1.4.13.1 | 2013‑12‑20 |
6.3.4.21.3 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.13.1 | IHE Vital Signs Organizer | 1.3.6.1.4.1.19376.1.5.3.1.4.13.1 | 2013‑12‑20 |
6.3.4.21.3 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.13.1 | IHE Vital Signs Organizer | 1.3.6.1.4.1.19376.1.5.3.1.4.13.1 | 2013‑12‑20 |
6.3.4.21.4 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.13.1 | IHE Vital Signs Organizer | 1.3.6.1.4.1.19376.1.5.3.1.4.13.1 | 2013‑12‑20 |
6.3.4.21.5 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.13.1 | IHE Vital Signs Organizer | 1.3.6.1.4.1.19376.1.5.3.1.4.13.1 | 2013‑12‑20 |
6.3.4.21.6 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.13.1 | IHE Vital Signs Organizer | 1.3.6.1.4.1.19376.1.5.3.1.4.13.1 | 2013‑12‑20 |
6.3.4.21.7 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.13.1 | IHE Vital Signs Organizer | 1.3.6.1.4.1.19376.1.5.3.1.4.13.1 | 2013‑12‑20 |
6.3.4.21.9 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.13.1 | IHE Vital Signs Organizer | 1.3.6.1.4.1.19376.1.5.3.1.4.13.1 | 2013‑12‑20 |
6.3.4.22 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.13.2 | IHE Vital Signs Observation | 1.3.6.1.4.1.19376.1.5.3.1.4.13.2 | 2016‑09‑29 09:22:49 |
6.3.4.22.2 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.13.2 | IHE Vital Signs Observation | 1.3.6.1.4.1.19376.1.5.3.1.4.13.2 | 2016‑09‑29 09:22:49 |
6.3.4.22.2 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.13.2 | IHE Vital Signs Observation | 1.3.6.1.4.1.19376.1.5.3.1.4.13.2 | 2016‑09‑29 09:22:49 |
6.3.4.22.2 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.13.2 | IHE Vital Signs Observation | 1.3.6.1.4.1.19376.1.5.3.1.4.13.2 | 2016‑09‑29 09:22:49 |
6.3.4.25 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.13.5 | IHE Pregnancy Observation | 1.3.6.1.4.1.19376.1.5.3.1.4.13.5 | 2016‑10‑21 14:59:35 |
6.3.4.26 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.13.5.1 | IHE Pregnancy History Organizer | 1.3.6.1.4.1.19376.1.5.3.1.4.13.5.1 | 2017‑03‑15 14:13:23 |
6.3.4.27 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.13.5.2 | IHE Birth Event Organizer | 1.3.6.1.4.1.19376.1.5.3.1.4.13.5.2 | 2017‑03‑15 13:46:49 |
6.3.4.3 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.1 | IHE Severity Entry | 1.3.6.1.4.1.19376.1.5.3.1.4.1 | 2013‑12‑20 |
6.3.4.3.3.1 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.3 | IHE Pharmaceutical Advice Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.3 | 2018‑01‑11 11:13:04 |
6.3.4.3.3.10 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.3 | IHE Pharmaceutical Advice Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.3 | 2018‑01‑11 11:13:04 |
6.3.4.3.3.10 | ![]() |
chdachpharm-template-entry-44 | Pharmaceutical Advice Item Entry Content Module | 2.16.756.5.30.1.1.10.4.44 | 2016‑06‑25 |
6.3.4.3.3.10 | ![]() |
chdachpharm-template-entry-81 | Pharmaceutical Advice Concern Entry Content Module | 2.16.756.5.30.1.1.10.4.81 | 2016‑01‑11 11:13:04 |
6.3.4.3.3.11 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.3 | IHE Pharmaceutical Advice Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.3 | 2018‑01‑11 11:13:04 |
6.3.4.3.3.11 | ![]() |
chdachpharm-template-entry-44 | Pharmaceutical Advice Item Entry Content Module | 2.16.756.5.30.1.1.10.4.44 | 2016‑06‑25 |
6.3.4.3.3.12 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.3 | IHE Pharmaceutical Advice Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.3 | 2018‑01‑11 11:13:04 |
6.3.4.3.3.12 | ![]() |
chdachpharm-template-entry-44 | Pharmaceutical Advice Item Entry Content Module | 2.16.756.5.30.1.1.10.4.44 | 2016‑06‑25 |
6.3.4.3.3.13 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.3 | IHE Pharmaceutical Advice Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.3 | 2018‑01‑11 11:13:04 |
6.3.4.3.3.13 | ![]() |
chdachpharm-template-entry-44 | Pharmaceutical Advice Item Entry Content Module | 2.16.756.5.30.1.1.10.4.44 | 2016‑06‑25 |
6.3.4.3.3.14 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.3 | IHE Pharmaceutical Advice Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.3 | 2018‑01‑11 11:13:04 |
6.3.4.3.3.14 | ![]() |
chdachpharm-template-entry-44 | Pharmaceutical Advice Item Entry Content Module | 2.16.756.5.30.1.1.10.4.44 | 2016‑06‑25 |
6.3.4.3.3.18 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.4 | IHE Dispense Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.4 | 2018‑01‑11 11:13:04 |
6.3.4.3.3.18 | ![]() |
chdachpharm-template-entry-42 | Dispense Item Entry Content Module | 2.16.756.5.30.1.1.10.4.42 | 2016‑06‑17 |
6.3.4.3.3.2 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.3 | IHE Pharmaceutical Advice Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.3 | 2018‑01‑11 11:13:04 |
6.3.4.3.3.2 | ![]() |
chdachpharm-template-entry-44 | Pharmaceutical Advice Item Entry Content Module | 2.16.756.5.30.1.1.10.4.44 | 2016‑06‑25 |
6.3.4.3.3.3 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.3 | IHE Pharmaceutical Advice Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.3 | 2018‑01‑11 11:13:04 |
6.3.4.3.3.3 | ![]() |
chdachpharm-template-entry-44 | Pharmaceutical Advice Item Entry Content Module | 2.16.756.5.30.1.1.10.4.44 | 2016‑06‑25 |
6.3.4.3.3.4 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.3 | IHE Pharmaceutical Advice Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.3 | 2018‑01‑11 11:13:04 |
6.3.4.3.3.4 | ![]() |
chdachpharm-template-entry-44 | Pharmaceutical Advice Item Entry Content Module | 2.16.756.5.30.1.1.10.4.44 | 2016‑06‑25 |
6.3.4.3.3.5 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.3 | IHE Pharmaceutical Advice Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.3 | 2018‑01‑11 11:13:04 |
6.3.4.3.3.5 | ![]() |
chdachpharm-template-entry-44 | Pharmaceutical Advice Item Entry Content Module | 2.16.756.5.30.1.1.10.4.44 | 2016‑06‑25 |
6.3.4.3.3.6 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.3 | IHE Pharmaceutical Advice Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.3 | 2018‑01‑11 11:13:04 |
6.3.4.3.3.6 | ![]() |
chdachpharm-template-entry-44 | Pharmaceutical Advice Item Entry Content Module | 2.16.756.5.30.1.1.10.4.44 | 2016‑06‑25 |
6.3.4.3.3.7 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.3 | IHE Pharmaceutical Advice Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.3 | 2018‑01‑11 11:13:04 |
6.3.4.3.3.7 | ![]() |
chdachpharm-template-entry-44 | Pharmaceutical Advice Item Entry Content Module | 2.16.756.5.30.1.1.10.4.44 | 2016‑06‑25 |
6.3.4.3.3.8 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.3 | IHE Pharmaceutical Advice Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.3 | 2018‑01‑11 11:13:04 |
6.3.4.3.3.8 | ![]() |
chdachpharm-template-entry-44 | Pharmaceutical Advice Item Entry Content Module | 2.16.756.5.30.1.1.10.4.44 | 2016‑06‑25 |
6.3.4.3.3.9 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.3 | IHE Pharmaceutical Advice Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.3 | 2018‑01‑11 11:13:04 |
6.3.4.3.3.9 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.3 | IHE Pharmaceutical Advice Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.3 | 2018‑01‑11 11:13:04 |
6.3.4.3.3.9 | ![]() |
chdachpharm-template-entry-44 | Pharmaceutical Advice Item Entry Content Module | 2.16.756.5.30.1.1.10.4.44 | 2016‑06‑25 |
6.3.4.3.3.9 | ![]() |
chdachpharm-template-entry-44 | Pharmaceutical Advice Item Entry Content Module | 2.16.756.5.30.1.1.10.4.44 | 2016‑06‑25 |
6.3.4.3.3.9 | ![]() |
chdachpharm-template-entry-81 | Pharmaceutical Advice Concern Entry Content Module | 2.16.756.5.30.1.1.10.4.81 | 2016‑01‑11 11:13:04 |
6.3.4.4 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.1.1 | IHE Problem Status Observation | 1.3.6.1.4.1.19376.1.5.3.1.4.1.1 | 2013‑12‑20 |
6.3.4.4.3.2 | ![]() |
chdachpharm-template-entry-81 | Pharmaceutical Advice Concern Entry Content Module | 2.16.756.5.30.1.1.10.4.81 | 2016‑01‑11 11:13:04 |
6.3.4.4.3.2 | ![]() |
chdachpharm-template-entry-81 | Pharmaceutical Advice Concern Entry Content Module | 2.16.756.5.30.1.1.10.4.81 | 2016‑01‑11 11:13:04 |
6.3.4.4.3.2 | ![]() |
chdachpharm-template-entry-81 | Pharmaceutical Advice Concern Entry Content Module | 2.16.756.5.30.1.1.10.4.81 | 2016‑01‑11 11:13:04 |
6.3.4.4.3.3 | ![]() |
chdachpharm-template-entry-81 | Pharmaceutical Advice Concern Entry Content Module | 2.16.756.5.30.1.1.10.4.81 | 2016‑01‑11 11:13:04 |
6.3.4.4.3.4 | ![]() |
chdachpharm-template-entry-81 | Pharmaceutical Advice Concern Entry Content Module | 2.16.756.5.30.1.1.10.4.81 | 2016‑01‑11 11:13:04 |
6.3.4.4.3.5 | ![]() |
chdachpharm-template-entry-81 | Pharmaceutical Advice Concern Entry Content Module | 2.16.756.5.30.1.1.10.4.81 | 2016‑01‑11 11:13:04 |
6.3.4.4.3.6 | ![]() |
chdachpharm-template-entry-81 | Pharmaceutical Advice Concern Entry Content Module | 2.16.756.5.30.1.1.10.4.81 | 2016‑01‑11 11:13:04 |
6.3.4.4.3.7 | ![]() |
chdachpharm-template-entry-81 | Pharmaceutical Advice Concern Entry Content Module | 2.16.756.5.30.1.1.10.4.81 | 2016‑01‑11 11:13:04 |
6.3.4.4.3.8 | ![]() |
chdachpharm-template-entry-81 | Pharmaceutical Advice Concern Entry Content Module | 2.16.756.5.30.1.1.10.4.81 | 2016‑01‑11 11:13:04 |
6.3.4.5 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.1.2 | IHE Health Status Observation | 1.3.6.1.4.1.19376.1.5.3.1.4.1.2 | 2013‑12‑20 |
6.3.4.5.3.1 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.4 | IHE Dispense Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.4 | 2018‑01‑11 11:13:04 |
6.3.4.5.3.10 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.4 | IHE Dispense Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.4 | 2018‑01‑11 11:13:04 |
6.3.4.5.3.10 | ![]() |
chdachpharm-template-entry-42 | Dispense Item Entry Content Module | 2.16.756.5.30.1.1.10.4.42 | 2016‑06‑17 |
6.3.4.5.3.11 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.4 | IHE Dispense Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.4 | 2018‑01‑11 11:13:04 |
6.3.4.5.3.11 | ![]() |
chdachpharm-template-entry-42 | Dispense Item Entry Content Module | 2.16.756.5.30.1.1.10.4.42 | 2016‑06‑17 |
6.3.4.5.3.12 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.4 | IHE Dispense Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.4 | 2018‑01‑11 11:13:04 |
6.3.4.5.3.12 | ![]() |
chdachpharm-template-entry-42 | Dispense Item Entry Content Module | 2.16.756.5.30.1.1.10.4.42 | 2016‑06‑17 |
6.3.4.5.3.13 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.4 | IHE Dispense Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.4 | 2018‑01‑11 11:13:04 |
6.3.4.5.3.13 | ![]() |
chdachpharm-template-entry-42 | Dispense Item Entry Content Module | 2.16.756.5.30.1.1.10.4.42 | 2016‑06‑17 |
6.3.4.5.3.14 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.4 | IHE Dispense Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.4 | 2018‑01‑11 11:13:04 |
6.3.4.5.3.14 | ![]() |
chdachpharm-template-entry-42 | Dispense Item Entry Content Module | 2.16.756.5.30.1.1.10.4.42 | 2016‑06‑17 |
6.3.4.5.3.19 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.4 | IHE Dispense Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.4 | 2018‑01‑11 11:13:04 |
6.3.4.5.3.19 | ![]() |
chdachpharm-template-entry-42 | Dispense Item Entry Content Module | 2.16.756.5.30.1.1.10.4.42 | 2016‑06‑17 |
6.3.4.5.3.19 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.9.2 | IHE Substitution Act Content Module | 1.3.6.1.4.1.19376.1.9.1.3.9.2 | 2018‑01‑10 15:34:25 |
6.3.4.5.3.19 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.9.2 | IHE Substitution Act Content Module | 1.3.6.1.4.1.19376.1.9.1.3.9.2 | 2018‑01‑10 15:34:25 |
6.3.4.5.3.2 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.4 | IHE Dispense Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.4 | 2018‑01‑11 11:13:04 |
6.3.4.5.3.2 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.4 | IHE Dispense Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.4 | 2018‑01‑11 11:13:04 |
6.3.4.5.3.2 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.4 | IHE Dispense Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.4 | 2018‑01‑11 11:13:04 |
6.3.4.5.3.2 | ![]() |
chdachpharm-template-entry-42 | Dispense Item Entry Content Module | 2.16.756.5.30.1.1.10.4.42 | 2016‑06‑17 |
6.3.4.5.3.2 | ![]() |
chdachpharm-template-entry-42 | Dispense Item Entry Content Module | 2.16.756.5.30.1.1.10.4.42 | 2016‑06‑17 |
6.3.4.5.3.2 | ![]() |
chdachpharm-template-entry-42 | Dispense Item Entry Content Module | 2.16.756.5.30.1.1.10.4.42 | 2016‑06‑17 |
6.3.4.5.3.3 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.4 | IHE Dispense Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.4 | 2018‑01‑11 11:13:04 |
6.3.4.5.3.3 | ![]() |
chdachpharm-template-entry-42 | Dispense Item Entry Content Module | 2.16.756.5.30.1.1.10.4.42 | 2016‑06‑17 |
6.3.4.5.3.4 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.4 | IHE Dispense Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.4 | 2018‑01‑11 11:13:04 |
6.3.4.5.3.4 | ![]() |
chdachpharm-template-entry-42 | Dispense Item Entry Content Module | 2.16.756.5.30.1.1.10.4.42 | 2016‑06‑17 |
6.3.4.5.3.5 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.10 | IHE MTP Reference Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.10 | 2016‑07‑07 |
6.3.4.5.3.5 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.4 | IHE Dispense Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.4 | 2018‑01‑11 11:13:04 |
6.3.4.5.3.5 | ![]() |
chdachpharm-template-entry-42 | Dispense Item Entry Content Module | 2.16.756.5.30.1.1.10.4.42 | 2016‑06‑17 |
6.3.4.5.3.5 | ![]() |
chdachpharm-template-entry-45 | MTP Reference Entry Content Module | 2.16.756.5.30.1.1.10.4.45 | 2017‑01‑10 15:34:25 |
6.3.4.5.3.6 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.10 | IHE MTP Reference Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.10 | 2016‑07‑07 |
6.3.4.5.3.7 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.10 | IHE MTP Reference Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.10 | 2016‑07‑07 |
6.3.4.5.3.7 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.4 | IHE Dispense Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.4 | 2018‑01‑11 11:13:04 |
6.3.4.5.3.7 | ![]() |
chdachpharm-template-entry-42 | Dispense Item Entry Content Module | 2.16.756.5.30.1.1.10.4.42 | 2016‑06‑17 |
6.3.4.5.3.7 | ![]() |
chdachpharm-template-entry-45 | MTP Reference Entry Content Module | 2.16.756.5.30.1.1.10.4.45 | 2017‑01‑10 15:34:25 |
6.3.4.5.3.8 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.4 | IHE Dispense Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.4 | 2018‑01‑11 11:13:04 |
6.3.4.5.3.8 | ![]() |
chdachpharm-template-entry-42 | Dispense Item Entry Content Module | 2.16.756.5.30.1.1.10.4.42 | 2016‑06‑17 |
6.3.4.51 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.12.1 | IHE Antigen Dose entry | 1.3.6.1.4.1.19376.1.5.3.1.4.12.1 | 2016‑09‑28 13:50:21 |
6.3.4.7 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.3 | IHE Patient Medication Instructions | 1.3.6.1.4.1.19376.1.5.3.1.4.3 | 2013‑12‑20 |
6.3.4.7.4 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.3 | IHE Patient Medication Instructions | 1.3.6.1.4.1.19376.1.5.3.1.4.3 | 2013‑12‑20 |
6.3.4.7.5 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.3 | IHE Patient Medication Instructions | 1.3.6.1.4.1.19376.1.5.3.1.4.3 | 2013‑12‑20 |
6.3.4.7.5 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.3 | IHE Patient Medication Instructions | 1.3.6.1.4.1.19376.1.5.3.1.4.3 | 2013‑12‑20 |
6.3.4.7.6 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.3 | IHE Patient Medication Instructions | 1.3.6.1.4.1.19376.1.5.3.1.4.3 | 2013‑12‑20 |
6.3.4.7.7 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.3 | IHE Patient Medication Instructions | 1.3.6.1.4.1.19376.1.5.3.1.4.3 | 2013‑12‑20 |
6.3.4.7.8 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.3 | IHE Patient Medication Instructions | 1.3.6.1.4.1.19376.1.5.3.1.4.3 | 2013‑12‑20 |
6.3.4.8 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.3.1 | IHE Medication FulFillment Instructions | 1.3.6.1.4.1.19376.1.5.3.1.4.3.1 | 2013‑12‑20 |
6.3.4.8 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.9.1 | IHE Substitution Permission Content Module | 1.3.6.1.4.1.19376.1.9.1.3.9.1 | 2018‑01‑10 15:34:25 |
6.3.4.8.4 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.3.1 | IHE Medication FulFillment Instructions | 1.3.6.1.4.1.19376.1.5.3.1.4.3.1 | 2013‑12‑20 |
6.3.4.8.5 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.3.1 | IHE Medication FulFillment Instructions | 1.3.6.1.4.1.19376.1.5.3.1.4.3.1 | 2013‑12‑20 |
6.3.4.8.5 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.3.1 | IHE Medication FulFillment Instructions | 1.3.6.1.4.1.19376.1.5.3.1.4.3.1 | 2013‑12‑20 |
6.3.4.8.6 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.3.1 | IHE Medication FulFillment Instructions | 1.3.6.1.4.1.19376.1.5.3.1.4.3.1 | 2013‑12‑20 |
6.3.4.8.7 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.3.1 | IHE Medication FulFillment Instructions | 1.3.6.1.4.1.19376.1.5.3.1.4.3.1 | 2013‑12‑20 |
6.3.4.8.8 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.3.1 | IHE Medication FulFillment Instructions | 1.3.6.1.4.1.19376.1.5.3.1.4.3.1 | 2013‑12‑20 |
6.3.4.9.3.1 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.10 | IHE MTP Reference Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.10 | 2016‑07‑07 |
6.3.4.9.3.1 | ![]() |
chdachpharm-template-entry-45 | MTP Reference Entry Content Module | 2.16.756.5.30.1.1.10.4.45 | 2017‑01‑10 15:34:25 |
6.3.4.9.3.2 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.10 | IHE MTP Reference Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.10 | 2016‑07‑07 |
6.3.4.9.3.2 | ![]() |
chdachpharm-template-entry-45 | MTP Reference Entry Content Module | 2.16.756.5.30.1.1.10.4.45 | 2017‑01‑10 15:34:25 |
6.3.4.9.3.3 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.10 | IHE MTP Reference Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.10 | 2016‑07‑07 |
6.3.4.9.3.3 | ![]() |
chdachpharm-template-entry-45 | MTP Reference Entry Content Module | 2.16.756.5.30.1.1.10.4.45 | 2017‑01‑10 15:34:25 |
6.3.4.9.3.4 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.10 | IHE MTP Reference Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.10 | 2016‑07‑07 |
6.3.4.9.3.4 | ![]() |
chdachpharm-template-entry-45 | MTP Reference Entry Content Module | 2.16.756.5.30.1.1.10.4.45 | 2017‑01‑10 15:34:25 |
6.3.4.93 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.15.2 | IHE Subject Participation | 1.3.6.1.4.1.19376.1.5.3.1.4.15.2 | 2017‑03‑15 09:59:00 |
6.3.4.93.2 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.15.2 | IHE Subject Participation | 1.3.6.1.4.1.19376.1.5.3.1.4.15.2 | 2017‑03‑15 09:59:00 |
6.3.4.93.3 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.15.2 | IHE Subject Participation | 1.3.6.1.4.1.19376.1.5.3.1.4.15.2 | 2017‑03‑15 09:59:00 |
6.3.4.93.8 | ![]() |
1.3.6.1.4.1.19376.1.5.3.1.4.15.2 | IHE Subject Participation | 1.3.6.1.4.1.19376.1.5.3.1.4.15.2 | 2017‑03‑15 09:59:00 |
6.3.4.E1 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.7 | IHE Medication Treatment Plan Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.7 | 2017‑03‑31 14:43:01 |
6.3.4.E1.3.1 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.7 | IHE Medication Treatment Plan Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.7 | 2017‑03‑31 14:43:01 |
6.3.4.E1.3.1 | ![]() |
chdachpharm-template-entry-34 | Medication Treatment Plan Item Entry Content Module | 2.16.756.5.30.1.1.10.4.34 | 2016‑06‑13 |
6.3.4.E1.3.1.5 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.7 | IHE Medication Treatment Plan Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.7 | 2017‑03‑31 14:43:01 |
6.3.4.E1.3.10 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.7 | IHE Medication Treatment Plan Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.7 | 2017‑03‑31 14:43:01 |
6.3.4.E1.3.11 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.7 | IHE Medication Treatment Plan Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.7 | 2017‑03‑31 14:43:01 |
6.3.4.E1.3.11 | ![]() |
chdachpharm-template-entry-34 | Medication Treatment Plan Item Entry Content Module | 2.16.756.5.30.1.1.10.4.34 | 2016‑06‑13 |
6.3.4.E1.3.12 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.7 | IHE Medication Treatment Plan Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.7 | 2017‑03‑31 14:43:01 |
6.3.4.E1.3.12 | ![]() |
chdachpharm-template-entry-34 | Medication Treatment Plan Item Entry Content Module | 2.16.756.5.30.1.1.10.4.34 | 2016‑06‑13 |
6.3.4.E1.3.13 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.7 | IHE Medication Treatment Plan Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.7 | 2017‑03‑31 14:43:01 |
6.3.4.E1.3.15 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.7 | IHE Medication Treatment Plan Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.7 | 2017‑03‑31 14:43:01 |
6.3.4.E1.3.15 | ![]() |
chdachpharm-template-entry-34 | Medication Treatment Plan Item Entry Content Module | 2.16.756.5.30.1.1.10.4.34 | 2016‑06‑13 |
6.3.4.E1.3.16 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.7 | IHE Medication Treatment Plan Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.7 | 2017‑03‑31 14:43:01 |
6.3.4.E1.3.16 | ![]() |
chdachpharm-template-entry-34 | Medication Treatment Plan Item Entry Content Module | 2.16.756.5.30.1.1.10.4.34 | 2016‑06‑13 |
6.3.4.E1.3.17 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.7 | IHE Medication Treatment Plan Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.7 | 2017‑03‑31 14:43:01 |
6.3.4.E1.3.17 | ![]() |
chdachpharm-template-entry-34 | Medication Treatment Plan Item Entry Content Module | 2.16.756.5.30.1.1.10.4.34 | 2016‑06‑13 |
6.3.4.E1.3.18 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.7 | IHE Medication Treatment Plan Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.7 | 2017‑03‑31 14:43:01 |
6.3.4.E1.3.18 | ![]() |
chdachpharm-template-entry-34 | Medication Treatment Plan Item Entry Content Module | 2.16.756.5.30.1.1.10.4.34 | 2016‑06‑13 |
6.3.4.E1.3.19 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.7 | IHE Medication Treatment Plan Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.7 | 2017‑03‑31 14:43:01 |
6.3.4.E1.3.19 | ![]() |
chdachpharm-template-entry-34 | Medication Treatment Plan Item Entry Content Module | 2.16.756.5.30.1.1.10.4.34 | 2016‑06‑13 |
6.3.4.E1.3.20 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.7 | IHE Medication Treatment Plan Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.7 | 2017‑03‑31 14:43:01 |
6.3.4.E1.3.20 | ![]() |
chdachpharm-template-entry-34 | Medication Treatment Plan Item Entry Content Module | 2.16.756.5.30.1.1.10.4.34 | 2016‑06‑13 |
6.3.4.E1.3.3 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.7 | IHE Medication Treatment Plan Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.7 | 2017‑03‑31 14:43:01 |
6.3.4.E1.3.3 | ![]() |
chdachpharm-template-entry-34 | Medication Treatment Plan Item Entry Content Module | 2.16.756.5.30.1.1.10.4.34 | 2016‑06‑13 |
6.3.4.E1.3.3 | ![]() |
chdachpharm-template-entry-42 | Dispense Item Entry Content Module | 2.16.756.5.30.1.1.10.4.42 | 2016‑06‑17 |
6.3.4.E1.3.4 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.2 | IHE Prescription Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.2 | 2018‑01‑11 13:04:49 |
6.3.4.E1.3.4 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.7 | IHE Medication Treatment Plan Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.7 | 2017‑03‑31 14:43:01 |
6.3.4.E1.3.4 | ![]() |
chdachpharm-template-entry-34 | Medication Treatment Plan Item Entry Content Module | 2.16.756.5.30.1.1.10.4.34 | 2016‑06‑13 |
6.3.4.E1.3.4 | ![]() |
chdachpharm-template-entry-43 | Prescription Item Entry Content Module | 2.16.756.5.30.1.1.10.4.43 | 2016‑06‑25 |
6.3.4.E1.3.6 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.7 | IHE Medication Treatment Plan Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.7 | 2017‑03‑31 14:43:01 |
6.3.4.E1.3.6 | ![]() |
chdachpharm-template-entry-34 | Medication Treatment Plan Item Entry Content Module | 2.16.756.5.30.1.1.10.4.34 | 2016‑06‑13 |
6.3.4.E1.3.7 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.7 | IHE Medication Treatment Plan Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.7 | 2017‑03‑31 14:43:01 |
6.3.4.E1.3.7 | ![]() |
chdachpharm-template-entry-34 | Medication Treatment Plan Item Entry Content Module | 2.16.756.5.30.1.1.10.4.34 | 2016‑06‑13 |
6.3.4.E1.3.8 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.7 | IHE Medication Treatment Plan Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.7 | 2017‑03‑31 14:43:01 |
6.3.4.E1.3.8 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.7 | IHE Medication Treatment Plan Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.7 | 2017‑03‑31 14:43:01 |
6.3.4.E1.3.8 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.7 | IHE Medication Treatment Plan Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.7 | 2017‑03‑31 14:43:01 |
CDA‑CH V2 | ![]() |
chdachpharm-template-header-1 | Patient - recordTarget | 2.16.756.5.30.1.1.10.2.1 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
chdachpharm-template-header-13 | Document Replacement - relatedDocument | 2.16.756.5.30.1.1.10.2.13 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
chdachpharm-template-header-14 | Insurance Card - participant | 2.16.756.5.30.1.1.10.2.14 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
chdachpharm-template-header-15 | Insurance - participant | 2.16.756.5.30.1.1.10.2.15 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
chdachpharm-template-header-16 | Order Reference - inFulfillmentOf | 2.16.756.5.30.1.1.10.2.16 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
chdachpharm-template-header-18 | Document Template Ids CDA-CH v2.0 - structuredBody | 2.16.756.5.30.1.1.10.2.18 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
chdachpharm-template-header-19 | Document Confidentiality Code | 2.16.756.5.30.1.1.10.2.19 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
chdachpharm-template-header-20 | Document Set Id and Version Number | 2.16.756.5.30.1.1.10.2.20 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
chdachpharm-template-header-22 | Document Language | 2.16.756.5.30.1.1.10.2.22 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
chdachpharm-template-header-23 | Document Id | 2.16.756.5.30.1.1.10.2.23 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
chdachpharm-template-header-25 | Document Realm | 2.16.756.5.30.1.1.10.2.25 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
chdachpharm-template-header-3 | Custodian | 2.16.756.5.30.1.1.10.2.3 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
chdachpharm-template-header-4 | Recipient - informationRecipient | 2.16.756.5.30.1.1.10.2.4 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
chdachpharm-template-header-40 | Employer - participant | 2.16.756.5.30.1.1.10.2.40 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
chdachpharm-template-header-43 | Patient Contact - participant | 2.16.756.5.30.1.1.10.2.43 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
chdachpharm-template-header-44 | Document Code | 2.16.756.5.30.1.1.10.2.44 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
chdachpharm-template-header-46 | Health Service - documentationOf | 2.16.756.5.30.1.1.10.2.46 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
chdachpharm-template-header-5 | Legal Authenticator | 2.16.756.5.30.1.1.10.2.5 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
chdachpharm-template-header-6 | Authenticator | 2.16.756.5.30.1.1.10.2.6 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
chdachpharm-template-header-7 | Data Enterer | 2.16.756.5.30.1.1.10.2.7 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
chdachpharm-template-section-2 | Remarks Section - coded | 2.16.756.5.30.1.1.10.3.2 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
chdachpharm-template-other-12 | Assigned Entity Compilation with id | 2.16.756.5.30.1.1.10.9.12 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
chdachpharm-template-other-14 | Narrative Text Reference | 2.16.756.5.30.1.1.10.9.14 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
chdachpharm-template-other-16 | Author Compilation with name, addr and telecom | 2.16.756.5.30.1.1.10.9.16 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
chdachpharm-template-other-21 | Device Compilation with name | 2.16.756.5.30.1.1.10.9.21 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
chdachpharm-template-other-23 | Author | 2.16.756.5.30.1.1.10.9.23 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
chdachpharm-template-other-24 | Organization Compilation with name | 2.16.756.5.30.1.1.10.9.24 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
chdachpharm-template-other-26 | Organization Compilation with GLN, name, addr and telecom | 2.16.756.5.30.1.1.10.9.26 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
chdachpharm-template-other-27 | Organization Compilation with name, addr, telecom | 2.16.756.5.30.1.1.10.9.27 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
chdachpharm-template-other-30 | Organization Compilation with GLN and name | 2.16.756.5.30.1.1.10.9.30 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
chdachpharm-template-other-32 | Assigned Entity Compilation with id, name, addr, telecom, person and organization | 2.16.756.5.30.1.1.10.9.32 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
chdachpharm-template-other-33 | Organization Compilation with id, name, addr and telecom | 2.16.756.5.30.1.1.10.9.33 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
chdachpharm-template-other-36 | CDA-CH v2.0 Header Template Compilation | 2.16.756.5.30.1.1.10.9.36 | 2018‑04‑18 |
CDA‑CH V2 | ![]() |
chdachpharm-template-other-49 | Original Text Reference | 2.16.756.5.30.1.1.10.9.49 | 2018‑04‑18 |
CH Special | ![]() |
chdachpharm-template-entry-34 | Medication Treatment Plan Item Entry Content Module | 2.16.756.5.30.1.1.10.4.34 | 2016‑06‑13 |
CH‑PHARM | ![]() |
chdachpharm-template-section-11 | Dispense Section Content Module | 2.16.756.5.30.1.1.10.3.11 | 2016‑06‑06 |
CH‑PHARM | ![]() |
chdachpharm-template-section-12 | Pharmaceutical Advice Section Content Module | 2.16.756.5.30.1.1.10.3.12 | 2016‑06‑06 |
CH‑PHARM | ![]() |
chdachpharm-template-section-12 | Pharmaceutical Advice Section Content Module | 2.16.756.5.30.1.1.10.3.12 | 2016‑06‑06 |
CH‑PHARM | ![]() |
chdachpharm-template-entry-81 | Pharmaceutical Advice Concern Entry Content Module | 2.16.756.5.30.1.1.10.4.81 | 2016‑01‑11 11:13:04 |
CH‑PHARM | ![]() |
chdachpharm-template-entry-81 | Pharmaceutical Advice Concern Entry Content Module | 2.16.756.5.30.1.1.10.4.81 | 2016‑01‑11 11:13:04 |
CH‑PHARM PRE | ![]() |
chdachpharm-template-section-10 | Prescription Section Content Module | 2.16.756.5.30.1.1.10.3.10 | 2016‑06‑06 |
CH‑PHARM PRE | ![]() |
chdachpharm-template-section-10 | Prescription Section Content Module | 2.16.756.5.30.1.1.10.3.10 | 2016‑06‑06 |
CH‑PHARM‑DispenseItemEntryContentModule | ![]() |
chdachpharm-template-entry-42 | Dispense Item Entry Content Module | 2.16.756.5.30.1.1.10.4.42 | 2016‑06‑17 |
CONF‑340 | ![]() |
2.16.840.1.113883.10.20.1.46 | Medication series number observation | 2.16.840.1.113883.10.20.1.46 | 2007‑04‑01 |
CONF‑341 | ![]() |
2.16.840.1.113883.10.20.1.46 | Medication series number observation | 2.16.840.1.113883.10.20.1.46 | 2007‑04‑01 |
CONF‑342 | ![]() |
2.16.840.1.113883.10.20.1.46 | Medication series number observation | 2.16.840.1.113883.10.20.1.46 | 2007‑04‑01 |
CONF‑343 | ![]() |
2.16.840.1.113883.10.20.1.46 | Medication series number observation | 2.16.840.1.113883.10.20.1.46 | 2007‑04‑01 |
CONF‑344 /CONF‑345 | ![]() |
2.16.840.1.113883.10.20.1.46 | Medication series number observation | 2.16.840.1.113883.10.20.1.46 | 2007‑04‑01 |
CONF‑346 / CONF‑347 | ![]() |
2.16.840.1.113883.10.20.1.46 | Medication series number observation | 2.16.840.1.113883.10.20.1.46 | 2007‑04‑01 |
CONF‑502 | ![]() |
2.16.840.1.113883.10.20.1.46 | Medication series number observation | 2.16.840.1.113883.10.20.1.46 | 2007‑04‑01 |
CONF‑503 | ![]() |
2.16.840.1.113883.10.20.1.40 | Comment | 2.16.840.1.113883.10.20.1.40 | 2007‑04‑01 |
CONF‑504 | ![]() |
2.16.840.1.113883.10.20.1.40 | Comment | 2.16.840.1.113883.10.20.1.40 | 2007‑04‑01 |
CONF‑505 | ![]() |
2.16.840.1.113883.10.20.1.40 | Comment | 2.16.840.1.113883.10.20.1.40 | 2007‑04‑01 |
CONF‑507 | ![]() |
2.16.840.1.113883.10.20.1.40 | Comment | 2.16.840.1.113883.10.20.1.40 | 2007‑04‑01 |
CONF‑537 / CONF‑538 / CONF‑539 | ![]() |
2.16.840.1.113883.3.1937.777.4.10.1 | CCD Person | 2.16.840.1.113883.3.1937.777.4.10.1 | 2007‑04‑01 |
CONF‑540 / CONF‑541 / CONF‑542 | ![]() |
2.16.840.1.113883.3.1937.777.4.10.3 | CCD Subject (Body) | 2.16.840.1.113883.3.1937.777.4.10.3 | 2007‑04‑01 |
CONF‑543 / CONF‑544 / CONF‑545 | ![]() |
2.16.840.1.113883.3.1937.777.4.10.3 | CCD Subject (Body) | 2.16.840.1.113883.3.1937.777.4.10.3 | 2007‑04‑01 |
CONF‑546 | ![]() |
2.16.840.1.113883.3.1937.777.4.10.1 | CCD Person | 2.16.840.1.113883.3.1937.777.4.10.1 | 2007‑04‑01 |
CONF‑547 | ![]() |
2.16.840.1.113883.3.1937.777.4.10.1 | CCD Person | 2.16.840.1.113883.3.1937.777.4.10.1 | 2007‑04‑01 |
CONF‑548 | ![]() |
2.16.840.1.113883.3.1937.777.4.10.1 | CCD Person | 2.16.840.1.113883.3.1937.777.4.10.1 | 2007‑04‑01 |
Dispense Section Content Module | ![]() |
chdachpharm-template-section-11 | Dispense Section Content Module | 2.16.756.5.30.1.1.10.3.11 | 2016‑06‑06 |
EMED | ![]() |
chdachpharm-template-entry-42 | Dispense Item Entry Content Module | 2.16.756.5.30.1.1.10.4.42 | 2016‑06‑17 |
IHE PARM PRE 6.3.4.8.3.1 | ![]() |
chdachpharm-template-entry-39 | Substitution Permission Entry Content Module | 2.16.756.5.30.1.1.10.4.39 | 2016‑09‑13 17:06:35 |
IHE PCC 6.3.4.16.20 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.2 | IHE Prescription Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.2 | 2018‑01‑11 13:04:49 |
IHE PCC 6.3.4.16.20 | ![]() |
1.3.6.1.4.1.19376.1.9.1.3.7 | IHE Medication Treatment Plan Item Entry Content Module | 1.3.6.1.4.1.19376.1.9.1.3.7 | 2017‑03‑31 14:43:01 |
IHE PCC 6.3.4.16.20 | ![]() |
chdachpharm-template-entry-36 | Dosage Instructions Dosage Change | 2.16.756.5.30.1.1.10.4.36 | 2017‑01‑23 16:30:55 |
IHE PCC TF2 Rev.11, 6.3.4.6 | ![]() |
chdachpharm-template-entry-2 | Annotation Comments | 2.16.756.5.30.1.1.10.4.2 | 2016‑11‑11 |
IHE PHARM DIS 6.3.3.3 | ![]() |
chdachpharm-template-section-11 | Dispense Section Content Module | 2.16.756.5.30.1.1.10.3.11 | 2016‑06‑06 |
IHE PHARM DIS 6.3.3.3 | ![]() |
chdachpharm-template-section-11 | Dispense Section Content Module | 2.16.756.5.30.1.1.10.3.11 | 2016‑06‑06 |
IHE PHARM DIS 6.3.3.3.2 | ![]() |
chdachpharm-template-section-11 | Dispense Section Content Module | 2.16.756.5.30.1.1.10.3.11 | 2016‑06‑06 |
IHE PHARM MTP 6.3.4.E1.3.12 | ![]() |
chdachpharm-template-entry-34 | Medication Treatment Plan Item Entry Content Module | 2.16.756.5.30.1.1.10.4.34 | 2016‑06‑13 |
IHE PHARM PADV 6.3.3.1 | ![]() |
chdachpharm-template-section-12 | Pharmaceutical Advice Section Content Module | 2.16.756.5.30.1.1.10.3.12 | 2016‑06‑06 |
IHE PHARM PADV 6.3.3.2 | ![]() |
chdachpharm-template-section-12 | Pharmaceutical Advice Section Content Module | 2.16.756.5.30.1.1.10.3.12 | 2016‑06‑06 |
IHE PHARM PADV 6.3.3.2.2 | ![]() |
chdachpharm-template-section-12 | Pharmaceutical Advice Section Content Module | 2.16.756.5.30.1.1.10.3.12 | 2016‑06‑06 |
IHE PHARM PADV 6.3.4.3 | ![]() |
chdachpharm-template-entry-44 | Pharmaceutical Advice Item Entry Content Module | 2.16.756.5.30.1.1.10.4.44 | 2016‑06‑25 |
IHE PHARM PRE 6.3.3.1 | ![]() |
chdachpharm-template-section-10 | Prescription Section Content Module | 2.16.756.5.30.1.1.10.3.10 | 2016‑06‑06 |
IHE PHARM PRE 6.3.3.1 | ![]() |
chdachpharm-template-section-10 | Prescription Section Content Module | 2.16.756.5.30.1.1.10.3.10 | 2016‑06‑06 |
IHE PHARM PRE 6.3.3.1.2 | ![]() |
chdachpharm-template-section-10 | Prescription Section Content Module | 2.16.756.5.30.1.1.10.3.10 | 2016‑06‑06 |
IHE PHARM PRE 6.3.4.1.3.4 | ![]() |
chdachpharm-template-entry-33 | Manufactured Material Entry Content Module | 2.16.756.5.30.1.1.10.4.33 | 2016‑06‑13 |
IHE PHARM PRE 6.3.4.1.3.6 | ![]() |
chdachpharm-template-entry-33 | Manufactured Material Entry Content Module | 2.16.756.5.30.1.1.10.4.33 | 2016‑06‑13 |
IHE PHARM PRE 6.3.4.1.3.7 | ![]() |
chdachpharm-template-entry-33 | Manufactured Material Entry Content Module | 2.16.756.5.30.1.1.10.4.33 | 2016‑06‑13 |
IHE PHARM PRE 6.3.4.1.3.8 | ![]() |
chdachpharm-template-entry-33 | Manufactured Material Entry Content Module | 2.16.756.5.30.1.1.10.4.33 | 2016‑06‑13 |
IHE PHARM PRE 6.3.4.2.3.16 | ![]() |
chdachpharm-template-entry-43 | Prescription Item Entry Content Module | 2.16.756.5.30.1.1.10.4.43 | 2016‑06‑25 |
IHE PHARM PRE 6.3.4.2.3.17 | ![]() |
chdachpharm-template-entry-38 | Prescribed Quantity Entry Content Module | 2.16.756.5.30.1.1.10.4.38 | 2016‑06‑13 |
IHE PHARM PRE 6.3.4.2.3.17 | ![]() |
chdachpharm-template-entry-39 | Substitution Permission Entry Content Module | 2.16.756.5.30.1.1.10.4.39 | 2016‑09‑13 17:06:35 |
IHE_Pharmacy_Suppl_MTP.pdf 6.3.1.D1 | ![]() |
1.3.6.1.4.1.19376.1.9.1.1.6 | IHE Medication Treatment Plan Document Content Module | 1.3.6.1.4.1.19376.1.9.1.1.6 | 2018‑01‑17 17:33:23 |
IHE_Pharmacy_Suppl_PRE.pdf 6.3.1.1 | ![]() |
1.3.6.1.4.1.19376.1.9.1.1.1 | IHE Community Prescription Content Module | 1.3.6.1.4.1.19376.1.9.1.1.1 | 2018‑01‑17 16:46:48 |
eCH‑0010 V7.0 addressInformation | ![]() |
chdachpharm-template-other-35 | Address Information Compilation - eCH-0010 | 2.16.756.5.30.1.1.10.9.35 | 2018‑04‑18 |
eCH‑0011 V8.1 nameData | ![]() |
chdachpharm-template-other-34 | Person Name Information Compilation - eCH-0011 | 2.16.756.5.30.1.1.10.9.34 | 2018‑04‑18 |
Data sets, codes, OIDs and Rules: this information is used for rendering and validation purposes.